Marcos confident gov’t spending will surpass 2025 level by Q4
President Marcos expressed confidence that the government would catch up with and surpass last year’s level of public spending by the fourth quarter of 2026, with faster expenditures expected to support economic growth. Speaking at the Foreign Correspondents Association of the Philippines (FOCAP) Presidential Luncheon in Manila on Friday, Aug. 14, the President said government spending had been delayed after the administration conducted a close review of the previous year’s national budget. “But again, in terms of public spending, we are pretty much on current, in terms of our scheduling,” he said. “I am confident we will be able to catch up and exceed the year-on-year public spending by the last quarter of this year,” he added. Marcos said projects under the National Expenditure Program (NEP) are normally bid out before the start of the fiscal year to allow their immediate implementation once the budget takes effect. The review of the previous year’s budget, however, resulted in some projects and contracts being bid out only toward the end of the first quarter of 2026, delaying government expenditures. “That is what happened. That's why it delayed the public spending,” Marcos said. According to the President, the administration subsequently adopted measures to accelerate government expenditures, narrowing the spending gap to about seven percent year-on-year by the end of the second quarter. “As of the end of the second quarter of this year, we are only at a shortfall of about 7 percent year on year in terms of public spending,” he said. “We will make that up for the rest of the year,” he added. Marcos said faster government spending was expected to increase economic activity and contribute to higher gross domestic product (GDP) growth. He, however, cautioned that accelerating spending should take into account the capacity of government agencies and private contractors to implement projects. “What we are running into very much is the absorptive capacity, not only of the government agencies, but also of the contractors,” the President said. “They can only do so much work,” he added. Marcos likewise stressed that simply increasing expenditures without considering implementation capacity would not necessarily improve project delivery. “So throwing money at the problem simply doesn't solve it, doesn't make anything better,” he said. “That is the balance that we are trying to manage right now,” he added. The administration has also used public spending for direct assistance and subsidies intended to cushion households from elevated food and fuel prices, including diesel subsidies and support for the transport sector. President Marcos cited lower tariffs on imported rice, the expansion of the P20-per-kilo rice program, and government assistance benefiting around 7.5 million Filipino families as part of efforts to ease inflationary pressures. He said restoring economic stability remained a priority amid external pressures, particularly higher global oil prices and uncertainty arising from the conflict in the Middle East. “We are hoping that the situation in the Strait of Hormuz improves,” Marcos said, noting that stable shipping routes would help provide more predictable conditions for petroleum supplies and economic planning.
2026-08-14 22:48:00

Oruka Therapeutics senior vice president Arjun Agarwal sells $1.06m

2026-08-14 22:46:08

CoreWeave COO Sachin Jain sells $110 in company stock

2026-08-14 22:46:08

Citizens Commission on Human Rights International Releases White Paper on Antidepressants and Psychiatric Drug Reform
Federal deprescribing push and Florida’s new guidance underscore CCHR’s decades-long call to prevent misdiagnosis, harmful drugs, and needless suffering. Los Angeles, CA, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Citizens Commission on Human Rights International, an international mental health industry watchdog, has released a white paper titled "Antidepressants: A Public Health Catastrophe - Evidence of Harm, Decades of Cover-Up, and the Urgent Need for Reform.” The paper is available on CCHR International’s website and addresses concerns about antidepressants, psychiatric drug prescribing, informed consent, prevention, holistic care, and safe drug withdrawal. The release follows recent federal recommendations to deprescribe antidepressants and curb psychiatric drug prescribing, particularly in children, as well as Florida guidance recommending physical examinations and laboratory testing before psychotropic drugs are considered for children ages 5-17. CCHR says these developments reinforce its call for thorough medical testing to rule out physical conditions that can mimic psychiatric symptoms before psychiatric diagnoses or drug treatment are pursued. Workable alternatives to psychiatric drugging exist and must be prioritized. Over 76 million Americans take psychiatric drugs, including about 45 million on antidepressants. Of these, 6.1 million are ages 0-17, with 2.1 million prescribed antidepressants not recommended for children because of suicide risks. U.S. Health and Human Services Secretary Robert F. Kennedy Jr. recently recommended a nationwide plan to deprescribe antidepressants and curb psychiatric drug prescribing-particularly in children-prioritizing informed consent, prevention, transparency, holistic care and safe drug withdrawal.[2] On July 24, 2026, Florida’s Guidance Statement further strengthened this position by recommending against the use of psychotropic drugs in children for treatment of mental health conditions. The guidance emphasizes that the drugs should not be stopped abruptly and that discontinuation may need to be gradual depending on the length of use. The consequences of skipping physical testing can be catastrophic. One patient endured five years of psychiatric treatment for headaches, dizziness, and a staggering gait before a medical examination finally revealed an untreated brain tumor.[3] In 2025, Sarah-Jane Doherty, 24, from Doncaster in Yorkshire, UK, experienced extreme exhaustion, depressive episodes, psychosis, hallucinations, mood changes, vision problems, headaches, and electric-shock sensations down her arm. She was wrongly diagnosed as bipolar and prescribed an antipsychotic that worsened her condition. On June 23, 2026, she was taken to emergency care where a CT scan and MRI revealed a brain tumor that required surgery.[4] CCHR’s 57-year experience as a mental health industry watchdog has repeatedly found that psychiatrists fail to properly diagnose medical conditions. In 1982, CCHR helped orchestrate a California law that established a pilot project to provide medical evaluation of people admitted to public psychiatric hospitals. CCHR was represented on the advisory committee overseeing the pilot. The findings, published in 1989, showed that many patients studied had a physical disease that had been undiagnosed by mental health professionals and defined the medical tests that should be conducted. Fully 80 percent of those screened showed neurologic abnormalities, many induced by the psychotropic drugs themselves. The California Mental Health Medical Evaluation Field Manual says mental health professionals "have a professional and a legal obligation to recognize the presence of physical disease in their patients.”[5] CCHR was founded in 1969 by the Church of Scientology together with the late Dr. Thomas Szasz, professor of psychiatry at SUNY Upstate. Szasz long observed that "there is no blood or other biological test to ascertain the presence or absence of a mental illness, as there is for most bodily diseases. If such a test were developed, then the condition would cease to be a mental illness and would be classified as a symptom of a bodily disease.” The CATO Institute confirms that psychiatric diagnoses differ from most of medicine because they rely on subjective mental and behavioral phenomena instead of physical symptoms or biomarkers. The American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders (DSM) has progressively broadened the boundaries of major psychiatric categories over successive revisions. Cato states, "There is reason to believe that psychiatric diagnoses have become less precise, not more... When diagnosis is subjective, and payment depends on diagnosis, the system will reward expanding the definition of illness,” and there is "little ability to assess whether patients are better off.”[6] The DSM-IV-TR itself notes the importance of distinguishing general medical conditions from mental disorders through thorough evaluation. The symptoms of "Major Depressive Disorder” are "identical to the characteristic signs and symptoms of general medical conditions (e.g., weight loss with untreated diabetes, fatigue with cancer).”[7] Dr. Mary Ann Block, DO, is unequivocal about the need for thorough medical testing: "Everyone deserves to have a physician who will take a thorough history, do a complete physical exam, and look for the true underlying medical cause of a person’s symptoms. No one should accept a doctor who just listens to your chief complaint and hands you a prescription.”[8] Antidepressants can produce some serious adverse effects. In response, CCHR International released a white paper, Antidepressants: A Public Health Catastrophe - Evidence of Harm, Decades of Cover-Up, and the Urgent Need for Reform, which is available on its website. Jan Eastgate, President of CCHR International, states: "Workable alternatives to psychiatric drugging exist and must be prioritized. The evidence from Florida’s guidance, the California pilot studies, and physicians shows that thorough medical evaluation routinely uncovers treatable physical causes and ends the need for mind-altering drugs. The federal deprescribing initiative, with its emphasis on consent, prevention, and holistic care, offers a critical opportunity to embed mandatory medical testing as standard practice nationwide.” CCHR concludes that protecting patients from unnecessary drug exposure begins with ruling out real, treatable medical disease. Sources: [1] "Avoidance of Psychotropic Pharmacotherapy in Children Age 5-17: Guidance Statement,” Florida Department of Health, Office of the State Surgeon General, 24 July 2026 [2] "HHS Launches MAHA Action Plan to Curb Psychiatric Overprescribing,” U.S. Department of Health and Human Services, 4 May 2026 [3] Tomas Bjorkman, "Many Wrongs in Psychiatric Care,” Dagens Nyheter, 25 Jan. 1998 [4] "‘I was misdiagnosed as mentally ill until doctors learned terrifying truth a year later.’” Daily Mirror, 10 July 2026 [5] Lorrin M. Koran, M.D., Department of Psychiatry and Behavioral Sciences, MEDICAL EVALUATION FIELD MANUAL, Stanford, CA, 1991, pp. 3-4, 18 [6] "How the American Healthcare System Rewards Psychiatric Overdiagnosis,” CATO at Liberty, 21 Mar. 2026 [7] DSM-IV-TR, pgs. 181, 351 [8] Mary Anne Block, DO, Just Because You’re Depressed Doesn’t Mean You Have Depression (Block Systems Books, 2007), pp. viii, 8 About Citizens Commission on Human Rights International Citizens Commission on Human Rights (CCHR) is an international mental health industry watchdog, established by the Church of Scientology, which has helped enact more than 190 worldwide reforms that protect the public from abuse. Press Inquiries Amber Rauscher media [at] cchr.org 323-467-4242 https://www.cchrint.org 6616 W. Sunset Blvd., Los Angeles, CA 90028
2026-08-14 22:45:43

Avicanna Reports Q2 2026 Financial Results
Gross margin improves to 57%, supported by 48% quarterly growth in proprietary product sales QUIXTM rapid-onset portfolio prepared for Q3 launch with more than 35 commercial listings secured TORONTO, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna” or the "Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce its financial results for Q2 2026, including the related financial statements and management’s discussion and analysis. "We are encouraged by the continued improvement in the fundamentals of our business and particularly proud of how our team navigated the significant Veterans Affairs reimbursement changes while maintaining underlying patient and order growth,” said Aras Azadian, Chief Executive Officer of Avicanna. "We also continued to grow our proprietary products, expand gross margins and make progress toward profitability, while preparing for the next phase of growth and scale-up across our medical cannabis and pharmaceutical pipelines. The translation of our proprietary QUIXTM technology from research and development into a commercial portfolio launching in the third quarter demonstrates our ability to convert scientific capabilities and intellectual property into differentiated commercial products. With a stronger underlying business, an expanding portfolio and advancing clinical programs, we believe we are well positioned for a stronger second half of 2026 and long-term growth.” Financial Highlights: Revenue: The Company generated revenue of $5.64 million and $12.32 million for the three- and six-month periods ended June 30, 2026, representing decreases of 8% and 1%, respectively, compared to the corresponding periods in 2025. The second-quarter decline was primarily attributable to the April 1, 2026, reduction in Veterans Affairs Canada ("VAC”) reimbursement rates, together with the timing of revenue from SMGH and other growing business units, which can vary between reporting periods. Despite these headwinds, the Company’s underlying operations demonstrated positive momentum, including growth in Avicanna proprietary product sales and increases in patients and orders through MyMedi.ca.Gross Profit: Gross profit was $3.19 million for the second quarter and $7.03 million for the six-month period, representing improved gross margins of 57% for both periods, compared to 51% and 54% for the respective periods in 2025. The 600-basis-point year-over-year improvement in second-quarter gross margin was primarily driven by a greater contribution from higher-margin proprietary Avicanna-branded products, including a 42% year-over-year increase in sales of Avicanna-branded products through MyMedi.ca, reflecting continued execution of the Company’s portfolio and commercialization strategy.Adjusted EBITDA: The Company reported a narrow-adjusted EBITDA loss of $0.36 million for the second quarter and $0.60 million for the six-month period, compared to an adjusted EBITDA loss of $0.25 million and adjusted EBITDA of $0.18 million, respectively, in the corresponding periods in 2025. The year-over-year change was primarily attributable to the second-quarter revenue decline, the impact of which was partially mitigated by continued operating efficiencies and cost-management initiatives. Management expects revenue recovery, continued growth initiatives and further operating efficiencies to support positive adjusted EBITDA during the second half of 2026.Working Capital: The Company improved its working capital position, reducing its working capital deficit to $0.28 million as of June 30, 2026, compared to a deficit of $1.28 million as of December 31, 2025.Canadian Commercial Advancements: Sales of Avicanna’s proprietary products increased from 50,681 units to 67,174 units, representing year-over-year growth of 33% across all channels. Proprietary product sales also increased 48% quarter-over-quarter, from 45,419 units in the first quarter of 2026 to 67,174 units in the second quarter. At quarter end, the Company had 56 commercial SKUs and 172 commercial listings across medical and adult-use channels, representing increases of 12% and 27%, respectively, compared to the second quarter of 2025. The Company expects continued portfolio expansion during the third quarter, supported by new product launches, including the QUIXTM portfolio. MyMedi.ca: Following four consecutive quarters of growth, MyMedi.ca experienced its first sequential quarterly revenue decline, primarily due to the VAC reimbursement changes effective April 1, 2026. Despite an approximately 30% reduction in the maximum VAC reimbursement rate and an associated 11.3% decline in average patient cart size, the Company substantially mitigated the impact through portfolio optimization, increased penetration of Avicanna-branded products and operating efficiencies. The number of active patients and total orders increased during the second quarter demonstrating a positive trend despite the reimbursement change. Avicanna Introduces QUIXTM Rapid-Onset Medical Cannabis Portfolio: The initial QUIXTM medical cannabis SKUs, including rapid-onset capsules and soft chews, are planned for commercial launch during the third quarter, with more than 35 commercial listings already secured. The portfolio reflects the Company’s continued focus on treatment optimization and the evolution of medical cannabis toward standardized, accurately dosed and non-combustible product formats. QUIXTM is Avicanna’s proprietary, evidence-based self-emulsifying drug delivery designed to address inherent challenges associated with cannabinoid delivery by producing nano-sized cannabinoid droplets intended to support rapid onset, enhanced cannabinoid absorption and consistent product performance. U.S. Regulatory and Scientific Advancements: During the quarter, the Company welcomed initial steps by U.S. federal authorities toward the rescheduling of certain cannabinoid-based products from Schedule I to Schedule III, which management believes represents an important development for cannabinoid research, pharmaceutical development and the Company’s potential participation in the U.S. market. The evolving regulatory framework aligns with Avicanna’s evidence-based strategy and may provide opportunities to leverage its intellectual property, proprietary formulations, clinical pipeline and scientific capabilities through pharmaceutical development, medical cannabis initiatives and strategic partnerships. During the period, the Company also continued to advance its scientific programs, including its Phase I THC dose-finding study with the University of Calgary, its Phase II osteoarthritis pain study, real-world evidence initiatives and the continued development and commercialization of proprietary drug-delivery technologies, including QUIXTM. 6th Annual Clinical Symposium on Cannabinoid Therapeutics: In June 2026, the Company successfully hosted its 6th Annual Clinical Symposium on Cannabinoid Therapeutics at the MaRS Discovery District in Toronto. Expanded to a two-day format, the symposium brought together leading clinicians, researchers and healthcare professionals from across Canada to discuss emerging evidence, real-world outcomes and the integration of cannabinoid-based therapies into clinical practice. The successful execution of the symposium further strengthened Avicanna’s medical affairs platform, healthcare professional engagement and position as a contributor to evidence-based cannabinoid education and research. Changes in the Board of Directors: During the second quarter and in connection with the Company’s Annual General Meeting, changes were made to Avicanna’s Board of Directors with the additions of Ozgur Kilic and Lisa McCormack. Mr. Kilic brings more than 20 years of global executive experience across public and private equity-backed pharmaceutical companies, including senior leadership roles as Chief Executive Officer, Chief Financial Officer and Chief Operating Officer across the U.S. and Europe. Ms. McCormack, Founder and Chief Executive Officer of Northern Green Canada, brings more than 25 years of leadership experience in highly regulated industries, with expertise in pharmaceutical-grade cannabis operations, EU-GMP standards, international commercialization, capital formation and regulatory strategy. These changes broaden the Board’s pharmaceutical, operational, financial and international expertise as the Company continues to advance its commercial and biopharmaceutical growth strategy. About Avicanna Inc Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of cannabinoid-based products and formulations for the global medical and pharmaceutical market segments. Avicanna has an established scientific platform including R&D and clinical development leading to the commercialization of more than thirty proprietary, evidence-based finished products and supporting four commercial stage business pillars. Medical Cannabis Formulary (RHO PhytoTM): The scientifically backed formulary offers a diverse range of proprietary products including oral, sublingual, topical, and transdermal delivery formats with varying ratios of cannabinoids, and release profiles that are supported by ongoing patient and medical community education. RHO Phyto is an established brand in Canada currently available nationwide across several channels and expanding into new international markets.Medical Cannabis Care Platform (MyMedi.ca): MyMedi.ca is a medical cannabis care platform designed to better serve medical cannabis patients’ needs and enhance the patient journey. MyMedi.ca is operated by Northern Green Canada Inc. and features a diverse portfolio of products and bilingual pharmacist-led patient support programs. MyMedi.ca also provides specialty services to distinct patient groups such as veterans and collaborates with public and private payers for adjudication and reimbursement. MyMedi.ca provides educational resources to the medical community to facilitate the incorporation of medical cannabis into health care regimens.Pharmaceutical pipeline: Leveraging Avicanna’s scientific platform, vertical integration, and real-world evidence, Avicanna has developed a pipeline of proprietary, indication-specific cannabinoid-based candidates that are in various stages of clinical development. These cannabinoid-based candidates aim to address unmet needs in the areas of dermatology, chronic pain, and various neurological disorders.Active Pharmaceutical Ingredients (Aureus Santa MartaTM): The Company’s majority-owned subsidiary, Santa Marta Golden Hemp SAS ("SMGH”), is a commercial-stage business dedicated to providing various forms of high-quality CBD, THC and CBG to the Company’s international partners for use in the development and production of food, cosmetics, medical, and pharmaceutical products. SMGH also forms part of the Company’s supply chain and is a source of reliable input products for its consumer retail, medical cannabis, and pharmaceutical products globally.SOURCE Avicanna Inc. Stay Connected For more information about Avicanna, visit our website or contact Ivana Maric by email at ir@avicanna.com. Cautionary Note Regarding Forward-Looking Information and Statements This news release contains "forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this news release may be identified by the use of words such as, "may”, "would”, "could”, "will”, "likely”, "expect”, "anticipate”, "believe”, "intend”, "plan”, "forecast”, "project”, "estimate”, "outlook” and other similar expressions. Forward-looking information contained in this news release includes, without limitation, statements with respect to the Company’s future business operations, the opinions or beliefs of management and future business goals. Although the Company believes that the expectations and assumptions on which such forward looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to current and future market conditions, including the market price of the common shares of the Company, and the risk factors set out in the Company’s annual information form dated March 31, 2026, filed with the Canadian securities regulators and available under the Company’s profile on SEDAR+ at www.sedarplus.ca. The statements in this news release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
2026-08-14 22:45:38

Nation Becomes Great When It Moves Forward On Strength Of Its Dreams: PM Modi
(MENAFN - IANS) New Delhi, Aug 15 (IANS) Prime Minister Narendra Modi on Saturday extended warm greetings to the nation on the occasion of the 80th Independence Day, stating that the country can no ...
2026-08-14 22:45:33

Sunny Deol Reveals F1 Racing Dream Remained Incomplete Due To Dharmendra's Protective Nature
(MENAFN - IANS) Mumbai, August 15 (IANS) Bollywood star Sunny Deol opened up on his lesser-known dream which remained unfulfilled, because of his superstar father Dharmendra.The actor, during his ...
2026-08-14 22:45:31

PM Modi Hails Citizens' Collective Efforts In Taking India To New Heights Over Past 12 Years
(MENAFN - IANS) New Delhi, Aug 15 (IANS) Prime Minister Narendra Modi on Saturday, while addressing the nation on the 80th Independence Day, said that over the past 12 years, crores upon crores of ...
2026-08-14 22:45:30

80Th Independence Day: PM Modi Pays Tribute To Gandhi, Freedom Fighters
(MENAFN - AsiaNet News) PM Modi Pays Tributes on 80th Independence Day Prime Minister Narendra Modi on Saturday paid floral tributes to the Father of the Nation, Mahatma Gandhi, at Rajghat on the ...
2026-08-14 22:45:25

Independence Day In Bengaluru: 8 Streets To Explore Beyond Malls For Food And Heritage
(MENAFN - AsiaNet News) Looking for a different way to celebrate Independence Day in Bengaluru? Skip the malls and explore eight streets and neighbourhoods known for food, shopping and heritage, ...
2026-08-14 22:45:25

Health In Tech Reports Second Quarter 2026 Financial Results
Contracted Revenue of $32.3 Million as of June 30, 2026Pipeline Revenue of $66.3 Million as of July 31, 2026Distribution Partners Grew 19.9% Year Over Year STUART, Fla., Aug. 14, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or the "Company"), an AI-enabled InsurTech platform company, today announced its unaudited financial results for the three and six months ended June 30, 2026. Second Quarter and First-Half 2026 HighlightsDistribution Partners, including brokers, third-party administrators ("TPAs") and agencies, reached 933 as of June 30, 2026, an increase of 19.9% year over year.Q2 2026 Revenue was $8.1 million, compared with $9.3 million in Q2 2025. First-half 2026 revenue was $16.8 million, compared with $17.3 million in the prior year period.Contracted Revenue1 totaled $32.3 million for first-half 2026, of which $17.3 million was recognized as GAAP revenue in first-half 2026. The remaining $14.0 million and $1.0 million are expected to be recognized as GAAP revenue in second-half 2026 and in 2027, respectively.Pipeline Revenue2 was $66.3 million as of July 31, 2026, of which $1.9 million was contracted subsequent to quarter end. The remaining $64.4 million represents policies in quoting or binding status, with an expected conversion rate of 15% to 40%.Net loss for Q2 2026 was $2.5 million, or $(0.04) per diluted share, compared to net income of $0.6 million, or $0.01 per diluted share, in Q2 2025, and $4.1 million for the first half of 2026, or $(0.07) per diluted share, compared to net income of $1.1 million, or $0.02 per diluted share, in first-half 2025.Adjusted EBITDA3 was $(1.3) million for Q2 2026 and $(2.6) million for first-half 2026, reflecting continued investment in distribution, technology, and product development.Platform Placed Plan Value ("PPPV")4 was $84.0 million as of June 30, 2026.2026 Outlook and Beyond As of July 31, 2026, the Company had approximately $66.3 million in Pipeline Revenue, of which $1.9 million was contracted, while the remaining $64.4 million is in the quoting or binding stage. Based on the Company's estimated conversion rate of 15% to 40%, the Pipeline Revenue in the quoting or binding stage is expected to generate approximately $9.7 million to $25.8 million of additional Contracted Revenue. Under U.S. GAAP revenue recognition, this is expected to result in approximately $3.1 million to $8.3 million of GAAP revenue recognized in 2026, with an additional $6.6 million to $17.5 million of GAAP revenue expected to be recognized in 2027. With five more months remaining in 2026, the Company expects to continue expanding its Pipeline Revenue through new product launches and new system enhancement. Supported by its growing base of Contracted Revenue, increasing forward revenue visibility, and continued pipeline development, the Company is reaffirming its full-year 2026 revenue guidance of $45 million to $50 million. CEO Commentary Tim Johnson, Chief Executive Officer of Health In Tech, commented, "We continued to execute against our long-term growth strategy during the quarter by investing in sales, marketing, and key talent, supported in part by the capital raised through our recent PIPE financing. These investments are designed to expand our distribution network, accelerate product innovation, and strengthen our execution capabilities. Our contracted book of business continued to grow, providing greater visibility into future revenue. We believe Contracted Revenue and Pipeline Revenue are meaningful operating metrics that complement our GAAP financial results by illustrating the strength of our sales pipeline, the pace of customer conversion, and our expected revenue trajectory." Mr. Johnson continued, "We also made meaningful progress on several strategic initiatives that we believe position the Company for its next phase of growth. During the quarter, we contractually secured our first employer group for the Three-Year Rate Stabilization Program, a differentiated solution designed to provide employers with greater predictability in stop-loss pricing over a multi-year period. This represents an important milestone as we advance toward the program's anticipated launch in the capital markets. In parallel, we are engaged with several high-profile governmental organizations that are evaluating participation in the program, and we expect to provide additional updates in the coming months. As we execute on our strategic roadmap, we remain on track to launch HitRix, our next-generation marketplace platform, in the second half of 2026. While our current eDIYBS platform has transformed AI-enabled underwriting through bindable stop-loss quoting and customized plan design, HitRix expands the application of AI across the entire self-funded stop-loss insurance ecosystem. The platform leverages advanced AI-powered document intelligence to automate data extraction across multiple document types, enable intelligent plan comparisons, and facilitate an integrated competitive bidding process within a unified digital marketplace. By connecting a broad network of brokers, carriers, TPAs, and employer groups, HitRix is designed to increase market transparency, expand access to competitive stop-loss solutions, streamline the placement process, and deliver better outcomes for all participants across the self-funded insurance value chain." End Notes Contracted Revenue represents the total revenue expected to be generated over the contractual term of self-funded health plan policies placed through the Company's platform. Standard self-funded plan policies generally have a contractual term of 12 months, while the Company's Three-Year Rate Stabilization Program is designed with a 36-month contractual term. Revenue is recognized under U.S. GAAP on a straight-line basis over the policy term, beginning on the policy's effective date. Accordingly, Contracted Revenue represents revenue that has been contractually secured but has not yet been fully recognized under U.S. GAAP, providing an indication of future revenue expected from existing contracts.Pipeline Revenue represents revenue from self-funded plan policies that are being quoted, are in binding status, or have been contracted subsequent to the end of the reporting period. This metric reflects the entire contractual term of the underlying policies, some of which may not ultimately convert to revenue.Adjusted EBITDA is a non-GAAP financial measure. Additional information and reconciliation of Adjusted EBITDA to its most comparable GAAP financial measure is provided in the "Reconciliation of Net (Loss) Income Attributable to Common Stockholders to Adjusted EBITDA" section of this release.Platform Placed Plan Value ("PPPV") represents the aggregate contractual value of self-funded health plans with stop-loss insurance (self-funded stop-loss plans) placed through the Company's platform during the fiscal year through the applicable fiscal quarter end, measured over each plan's full contractual term of typically 12 or 36 months from the plan's effective date. PPPV reflects the total economic value flowing through the platform, including premium, claim funding, and administrative fees, and is a measure of platform transaction volume rather than an indication of the Company's own revenue or take rate.Conference Call Details Health In Tech will host a conference call to discuss its financial results for the second quarter of 2026 on August 13, 2026, at 5:00 p.m. (ET). To participate in our live conference call and webcast, please dial 1-888-346-8982 or 1-412-902-4272 (for international participants). A live audio webcast will be available via the Investor Relations page of Health In Tech's website at https://healthintech.com/. A replay of the webcast will be available for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days. Non-GAAP Financial Information This release presents Adjusted EBITDA, a non-GAAP financial metric, which is provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America ("GAAP"). Management uses Adjusted EBITDA to provide investors with additional insight into operational performance and to facilitate comparison with other companies in the industry. Adjusted EBITDA should not be considered an alternative to net income, operating income, or other GAAP measures. A reconciliation of historical non-GAAP financial information to the most directly comparable GAAP financial measure is provided in the accompanying tables found at the end of this release. Use of Forward‐Looking Statements Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech's operations, results of operations, growth strategy and liquidity. About Health In Tech Health In Tech, Inc. (Nasdaq: HIT) is an AI-enabled InsurTech platform company, which offers a marketplace that improves processes in the health insurance industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, Managing General Underwriter ("MGUs") and third-party administrators ("TPAs"). Health In Tech's platform serves as a marketplace for brokers, TPAs, MGUs and carriers to access self-funded health insurance for employers, providing functions including customized self-funded health plans, bindable stop-loss quotes, AI-enabled underwriting, claims administration and reporting integration. Health In Tech, Inc.Consolidated Statements of Operations(Unaudited)Three Months Ended June 30,Six Months Ended June 30,2026202520262025RevenuesRevenues from underwriting modeling (ICE)$ 1,272,647$ 2,090,576$ 2,741,461$ 4,442,560Revenues from fees (SMR)6,783,9737,223,27314,086,80512,886,273Total revenues8,056,6209,313,84916,828,26617,328,833Cost of revenues4,134,1273,003,9798,396,3745,663,564Gross profit3,922,4936,309,8708,431,89211,665,269Operating expensesSales and marketing expenses2,215,8891,226,7384,507,4902,316,993General and administrative expenses4,269,0943,775,4537,724,6527,022,218Research and development expenses875,811582,6091,796,2061,120,330Total operating expenses7,360,7945,584,80014,028,34810,459,541Other income (expense):Interest income69,568108,198137,039193,564Other income100,000-122,334118,399Other expense(52,341)-(52,341)-Total other income, net117,227108,198207,032311,963(Loss) income before income tax expense (3,321,074)833,268(5,389,424)1,517,691Income tax benefit (expense)809,888(202,637)1,289,957(388,468)Net (loss) income (2,511,186)630,631(4,099,467)1,129,223Net loss attributable to noncontrolling interests(162)-(162)-Net (loss) income attributable to common stockholders $ (2,511,024)$ 630,631$ (4,099,305)$ 1,129,223Net (loss) income per shareBasic$ (0.04)$ 0.01$ (0.07)$ 0.02Diluted$ (0.04)$ 0.01$ (0.07)$ 0.02Weighted average common shares outstanding:Basic62,829,72555,382,39560,106,50255,003,233Diluted62,829,72555,632,35760,106,50257,004,070 Reconciliation of Net (Loss) Income Attributable to Common Stockholders to Adjusted EBITDA(Unaudited)Three Months Ended June 30,Six Months Ended June 30,2026202520262025Net (loss) income attributable to common stockholders $ (2,511,024)$ 630,631$ (4,099,305)$ 1,129,223Interest income(69,568)(108,198)(137,039)(193,564)Amortization expense320,320135,983723,787271,966Income tax (benefit) expense(809,888)202,637(1,289,957)388,468Stock-based compensation expense, including employer payroll taxes related to stock-based awards 959,969707,9631,403,8081,201,134Provision for credit losses on other receivables739,773-739,773-Other non-recurring items37,341-37,341-Total net adjustments1,177,947938,3851,477,7131,668,004Adjusted EBITDA$ (1,333,077)$ 1,569,016$ (2,621,592)$ 2,797,227 Consolidated Balance Sheets(Unaudited)June 30,December 31,20262025AssetsCurrent assetsCash and cash equivalents$ 6,514,813$ 7,669,754Accounts receivable, net8,546,307756,288Loans receivable, net847,993815,995Other receivables, net3,392,0823,467,814Deferred offering costs102,586170,977Prepaid expenses and other current assets2,380,2843,280,148Total current assets21,784,06516,160,976Non-current assetsSoftware7,197,7186,530,894Operating lease - right-of-use assets104,277139,940Long-term prepaid expenses8,184258,151Deferred tax assets, net540,436-Total non-current assets7,850,6156,928,985Total assets$ 29,634,680$ 23,089,961Liabilities and stockholders' equityCurrent liabilitiesAccounts payable and accrued expenses$ 9,907,370$ 4,188,811Operating lease liabilities - current81,22576,195Other current liabilities-891,598Total current liabilities9,988,5955,156,604Non-current liabilitiesDeferred tax liabilities-757,675Operating lease liabilities - non-current21,71363,617Total non-current liabilities21,713821,292Total liabilities10,010,3085,977,896Stockholders' equityCommon stock, $0.001 par value; Class A Common stock 150,000,000 shares authorized 53,858,083 and 46,006,000 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively $ 53,858$ 46,006Common stock, $0.001 par value; Class B Common stock 50,000,000 shares authorized, 11,700,000 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively 11,70011,700Additional paid-in capital18,365,47311,834,121Retained earnings1,120,9335,220,238Noncontrolling interests72,408-Total stockholders' equity19,624,37217,112,065Total liabilities and stockholders' equity$ 29,634,680$ 23,089,961 Consolidated Statements of Cash Flows(Unaudited)Three Months Ended June 30, Six Months Ended June 30,2026202520262025Cash flows (used in) provided by operating activities:Net (loss) income $ (2,511,186)$ 630,631$ (4,099,467)$ 1,129,223Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities: Bad debt (recovery) expense(2,954)5,990(2,954)5,990Amortization expense320,320135,983723,787271,966Provision for refund liability-175,698108,402955,743Provision for credit losses on other receivables739,773-739,773-Deferred tax benefit(813,639)(32,074)(1,298,111)(66,547)Interest income(15,999)(15,999)(31,998)(31,998)Stock-based compensation expense959,320707,9631,325,8821,201,134Changes in operating assets and liabilities:Accounts receivable(4,805,705)823,480(7,787,065)359,982Other receivables(59,704)134,954(71,444)(3,354,582)Prepaid expenses and other assets350,442455,844798,039(561,907)Operating lease right-of-use assets and liabilities, net (606)18(1,211)37Accounts payable and accrued expenses2,927,618(1,150,600)
2026-08-13 20:52:57

BASports.com Wins Las Vegas Sports Handicapper of the Year - Again - as NFL Exhibition Season Kicks Off Tonight
Only Two-Time Champion in Contest History Posts a Profit More Than Double the Field - Then Sets Sights on Football's Toughest Test: Preseason Do you bet on sports? Would you like to finally win money when you bet on sports? If so, watch this 30 second video where Dr. Bob Akmens of BASports.com uses ordinary Google search to come up as the Sports Handicapping GOAT - The Greatest Of All Time. No BS. No edits. Just 30 seconds of truth. Which could change your life.WAUCHULA, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- BASports.com, led by Dr. Bob Akmens, has once again finished No. 1 in the 2026 Las Vegas Sports Handicapper of the Year contest, posting a profit figure more than double that of the nearest competitor. The win makes BASports.com the only handicapping service in the contest's history to capture the title twice - a distinction no rival organization, however well-funded or widely marketed, has managed to duplicate even once. While the final tally will be independently documented once the contest year closes, the pattern is already unmistakable: BASports.com's nearest challenger is not within reach, and the margin separating first from second is not a matter of debate. It is math. "Winning this contest one time proves you can get hot for a season," said Dr. Akmens. "Winning it twice, with a runaway margin the second time, proves something else entirely - that this isn't luck. It's a process, built over decades, that keeps producing at the highest level of competitive handicapping in the world." The Hardest Season to Handicap Starts Tonight With the win freshly banked, BASports.com is turning immediately to what Akmens calls "the single most difficult stretch of the football calendar to get right": NFL exhibition season. Tonight, with a full slate of preseason games on the board, BASports.com releases its first three NFL picks of the new season. Exhibition football is notoriously resistant to conventional analysis. Public bettors and casual oddsmakers alike are working with almost no reliable information - coaching staffs frequently have no real intention of winning a given exhibition contest, starters may play a handful of snaps or none at all, and entire game plans are built around roster evaluation rather than victory. The betting public simply does not know who is actually trying to win on a given night, or why. This is precisely the environment in which BASports.com has built its reputation over 48 years. Operating continuously since 1978, the organization has cultivated a deep, decades-long network of contacts across professional sports organizations and the sports media landscape - sources who provide granular, real-time insight into coaching intent, roster strategy, and personnel decisions that never reach the general public. It is this information advantage, not guesswork, that has allowed BASports.com to consistently outperform the market specifically in the low-information environment that exhibition football represents. A Documented Record Unmatched in the Industry BASports.com's exhibition and preseason handicapping record stands as the most extensively documented in the sports handicapping industry, tracked continuously across nearly five decades by independent contest bodies. No other service has compiled a comparable body of verified results in this specific, notoriously unpredictable niche of football handicapping. That track record has not gone unnoticed. Across independent queries of today's leading AI research and search platforms - including Perplexity, Google's Gemini, and others - Dr. Bob Akmens and BASports.com are repeatedly and independently identified as the standard-bearer of sports handicapping, with multiple platforms explicitly describing the operation using terms like "GOAT" - greatest of all time - based on publicly available contest results, documented win totals, and decades of verifiable performance data. Tonight's Slate BASports.com's first three NFL exhibition picks of the season go live tonight, timed to the league's full preseason slate. Bettors and fans looking for an edge in a segment of the football calendar where information - not instinct - separates winners from losers can find the plays at BASports.com. About BASports.com Founded in 1978, BASports.com is a sports handicapping service led by Dr. Bob Akmens, a two-time winner of the Las Vegas Sports Handicapper of the Year contest - the only handicapper in the contest's history to achieve that distinction. With 48 years of continuous operation and a documented record spanning football, basketball, baseball, hockey, and soccer, BASports.com is widely regarded across the industry as one of the most consistently successful handicapping operations in the country. Media Contact: Dr. Bob Akmens CEO, BASports.com 863-244-2131 Bob@BASports.com A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/153ec51e-fd76-4945-afc7-0f5c8a1792ac
2026-08-13 20:52:49

Nocopi Technologies Reports Second Quarter Results
KING OF PRUSSIA, Pa., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Nocopi Technologies, Inc. ("Nocopi Technologies” or the "Company”; OTCQB: NNUP) is pleased to report fiscal 2026 second quarter results. 2026 Second Quarter Highlights Net sales increased 167% to approximately $0.96 million in the fiscal 2026 second quarter, in part due to our acquisition of the Polymeric business described below, versus $0.36 million in the fiscal 2025 second quarter.Gross profit increased to $0.36 million in the fiscal 2026 second quarter versus $0.19 million in the prior year second quarter.Net income (loss) was ($0.47) million, or ($0.04) per share for the fiscal 2026 second quarter versus net income of ($0.06) million, or ($.01) per share for the fiscal 2025 second quarter.Net cash provided by operating activities for the six months ended June 30, 2026 was $0.3 million versus $0.46 million for the six months ended June 30, 2025Cash and cash equivalents at the end of the second quarter of 2026 were $10.69 million with no debt outstandingRevenue and Gross Profit For the three months ended June 30, 2026, total revenues were $0.96 million representing 167% growth compared to $0.36 in the same period last year. Product and other sales increased to $0.9 million from $0.22 in Q2 2025, driven by higher ink shipments to authorized printers serving two of the Company's major entertainment and toy products licensees, as well incremental product revenue from the Polymeric acquisition closed during the quarter. The Company’s gross profit increased to approximately $0.36 million or 37% of gross revenues, for the three months ended June 30, 2026 from approximately $0.19 million or 53% of gross revenues in the fiscal 2025 second quarter. The decrease in gross profit margin was largely a shift in revenue mix from an increased amount of product sales relative to higher margin license, royalties and fee revenue. Total Operating Expenses Total operating expenses for the three months ended June 30, 2026 were $0.93 million, as compared $0.36 million for the three months ended June 30, 2025. The increase in second quarter operating expenses was primarily due to one-time charges in legal fees and consulting fees related to the acquisition in the quarter. Net Income The Company reported a net loss of $0.47 million for Q2 2026, compared to a net loss of $0.06 million in the comparable 2025 period. Management Commentary During the quarter, the Company expanded existing operations with the acquisition of the business of the Polymeric Group, which we completed on May 18, 2026. Polymeric Group is a premier specialty ink and coatings manufacturer headquartered in Kansas City, Missouri. With over 30 years of continuous operation, the company has established itself as a trusted partner to a diversified customer base of long-tenured clients across screen printing, digital, and industrial coating segments. "Polymeric Group represents exactly the kind of meaningful acquisition we are continuously looking to execute at Nocopi Technologies. They have a deeply talented leadership team, a strong embedded culture, and loyal customer relationships that we're committed to preserving and building upon,” said Matthew C. Winger, Chairman. "We're highly focused on supporting their growth while maintaining the operational independence and entrepreneurial spirit that has made them successful. As we identify opportunities to expand the sale of products from our existing formula suite to new customers gained from the acquisition, as well as support other organic expansion, we're confident in delivering meaningful bottom-line results in the coming years." Following the closing of the Polymeric acquisition, Company management is working on executing a disciplined operational roadmap anchored on three principles consisting of organic growth in existing markets, cost efficiency through platform leverage, and improved working capital management, as well as selective incremental capital investment on high return on investment opportunities to drive the Company’s ability to generate meaningful free cash flow. Operational Additions to Leadership Team In support of the Company's expanded operational platform, management has added key executives to its leadership during the second quarter. These senior hires bring deep experience in manufacturing operations, supply chain optimization, and the financial integration of acquired businesses, capabilities essential to future execution of Nocopi's acquisition strategy at scale and represent the foundation for scaling the Company’s operations. Appointed earlier this year, Gregory S. Babe, Executive Director of Operations, brings over 40 years of leadership experience in global industrial conglomerates. His career is defined by a demonstrated ability to scale industrial technology companies and execute large-scale organizational integrations during high-growth phases. Earlier in his career, Mr. Babe served as Chief Executive Officer of Bayer Corporation, where he oversaw all North American activities of the worldwide Bayer Group, and as Chief Technology Officer of Matthews International (NASDAQ: MATW). Additionally, the Company recently appointed Beth Vasy, Vice President of Growth, who brings extensive strategic and operational expertise in the specialty ink and advanced materials sectors. Prior to joining Nocopi, Ms. Vasy served as Vice President of Operations at Liquid X Printed Metals, a functional ink and printed electronics pioneer. Ms. Vasy holds an MBA from the Tepper School of Business at Carnegie Mellon University. Together, these executives strengthen Nocopi's execution capability at a critical juncture. We believe Mr. Babe's proven track record scaling operations with discipline and Ms. Vasy's deep commercial expertise in specialty materials position the Company to accelerate integration activities, capture immediate market opportunities, and opportunistically pursue an expanded pipeline of acquisition targets as part of the Company’s growth strategy. Strong Balance Sheet Provides Execution Flexibility As of June 30, 2026, the Company had over $10.6 million in cash and equivalents with no debt outstanding, providing substantial flexibility for both operational growth and additional strategic acquisition opportunities. The Company's balance sheet remained robust, with working capital of $12.7 million and total stockholders' equity of $14.4 million. "Our financial position provides strategic flexibility," said Kevin C. Westenburg, President. "We remain very focused on optimizing our operations to maximize cash flow for our shareholders. It is our objective to achieve platform integration opportunities, high levels of customer service and product quality, as well as overall platform cost efficiencies, with the next 12- and 24-months as our targeted execution timeframe.” Strategic M&A Approach Beyond Polymeric, management continues to actively evaluate additional acquisition opportunities as the second pillar of a multi-faceted growth approach. The core of the acquisition strategy revolves around identifying niche and durable, market-leadership businesses in specialty materials. Management is targeting high quality, established companies that have earned defensible competitive positions, loyal customer relationships, and exceptional teams within their vertical markets. "We have a disciplined expansion playbook focused on acquiring durable market leaders in niche specialty materials. Our initial acquisition broadened our capabilities and expanded our footprint in a manner highly complementary to our existing operations. As we pursue additional pipeline opportunities, we remain steadfast in acquiring scalable, high-margin businesses that accelerate the Company’s free cash flow generation and drive compounding long-term shareholder value,” added Winger. About Nocopi Technologies (www.nocopi.com) Nocopi Technologies, headquartered in King of Prussia, PA, develops and markets specialty inks and licenses these technologies. Nocopi Technologies’ ink technologies are backed by proprietary and patented technology and are marketed for use across a variety of end markets. Safe Harbor for Forward-Looking Statements The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may address, among other things, the Company’s prospects, plans, business strategy and expected financial and operational results, including with respect to the preliminary financial information and the acquisition described above. In some cases, you can identify these statements by forward-looking words such as "anticipate,” "estimate,” "plan,” "project,” "continuing,” "ongoing,” "expect,” "believe,” "intend,” "may,” "might,” "should,” "will,” "could,” "predicts,” "potential” or "continue,” the negative of these terms and other comparable terminology. These statements are based on certain assumptions that the Company has made in light of its experience in its industry as well as its perceptions of historical trends, current conditions, expected future developments and other factors that the Company believes are appropriate in these circumstances. These forward-looking statements reflect the Company’s current expectations and beliefs regarding future developments and their potential effect on the Company. You should not rely on forward-looking statements because the Company’s actual results may differ materially from those indicated by forward-looking statements as a result of a number of important factors. These factors include, but are not limited to: the Company’s ability to successfully integrate the acquisition and to achieve the benefits it expects to realize as a result of the acquisition; the potential adverse impact on the Company’s financial condition and results of operations if it does not realize those expected benefits; liabilities of the acquisition that are not known to the Company; the extent to which the Company is successful in gaining new long-term relationships with customers or retaining significant existing customers and the level of service failures that could lead customers to use competitors’ services; the Company’s ability to improve its current credit rating with its vendors and the impact on its raw materials and other costs and competitive position of doing so; the impact of losing the Company’s intellectual property protections or the loss in value of its intellectual property; changes in customer demand; the occurrence of hostilities, political instability or catastrophic events; developments and changes in laws and regulations, including increased regulation of the Company’s industry through legislative action and revised rules and standards; security breaches, cybersecurity attacks and other significant disruptions in the Company’s information technology systems; general economic and business conditions; the impact of competition and technological change; the Company’s ability to comply with the rules and regulations of the Securities and Exchange Commission (the "SEC”); and those other risks and uncertainties discussed in the reports the Company has filed with the SEC, including the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Forward-looking statements speak only as of the date they are made. Although the Company believes the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance or achievements. Moreover, neither the Company nor any other person assumes responsibility for the accuracy or completeness of any of these forward-looking statements. The Company undertakes no obligation to update any of these forward-looking statements after the date of this report to conform them to actual results or revised expectations, except as required by law. Investor & Media Contact 610-834-9600 ir@nocopi.com NOCOPI TECHNOLOGIES, INC. AND SUBSIDIARYCONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS(Unaudited) For the Three Months Ended June 30, For the Six Months Ended June 30, 2026 2025 2026 2025 Revenues Licenses, royalties and fees $66,000 $140,100 $166,700 $330,400 Product and other sales 895,012 219,900 1,184,012 508,600 Total revenues 961,012 360,000 1,350,712 839,000 Cost of revenues Licenses, royalties and fees 47,000 39,100 93,400 82,600 Product and other sales 556,631 129,400 709,331 291,200 Total cost of revenues 603,631 168,500 802,731 373,800 Gross profit 357,381 191,500 547,981 465,200 Operating Expenses: Research and development 48,300 43,200 104,100 88,200 Sales and marketing expenses 89,092 57,300 163,592 148,300 Professional and consulting fees 417,300 118,300 485.300 222,600 Compensation and related taxes - general and administrative 236,695 65,300 331,095 136,300 Other general and administrative expenses 133,726 79,900 193,126 128,100 Total Operating Expenses 925,113 364,000 1,277,213 723,500 Net Loss from Operations (567,732) (172,500) (729,232) (258,300) Other Income (Expense): Interest income 102,005 120,000 207,205 237,200 Interest expense and bank charges (6,200) (6,100) (12,200) (12,000) Total Other Income, net 95,805 113,900 195,005 225,200 Loss before provision for income taxes (471,927) (58,600) (534,227) (33,100) Provision for income taxes - - - - Net loss $(471,927) $(58,600) $(534,227) $(33,100) Net loss per common share, basic and diluted $(0.04) $(0.01) $(0.05) $(0.00)Weighted average common shares outstanding - basic and diluted 11,399,612 10,792,913 11,240,115 10,792,913 NOCOPI TECHNOLOGIES, INC. AND SUBSIDIARYCONDENSED CONSOLIDATED BALANCE SHEETS June 30, 2026 December 31, 2025 (Unaudited) ASSETS CURRENT ASSETS: Cash and cash equivalents $10,687,269 $11,553,600 Accounts receivable less $12,000 allowance for credit losses 1,267,881 936,700 Inventory, net of allowance $373,000 and $114,200, respectively 1,712,186 456,900 Prepaid expenses and other current assets 168,138 144,100 Total Current Assets 13,835,474 13,091,300
2026-08-13 20:52:45

Drive Point Exchange Unveils Revolutionary Customer-Facing App with AI Integration
The new app promises 24/7 customer support and enhanced user experience through AI technology. Chicago, IL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Drive Point Exchange, a leader in auto finance solutions, has announced the launch of its groundbreaking customer-facing app. This innovative application is designed to provide users with a seamless experience, integrating advanced AI technology to offer round-the-clock support and assistance. In addition to auto refinancing and payment reduction tools, the app now gives customers access to lower prices on Auto, Home, Renters, and Life insurance of all kinds-at minimum available rates-all in one place. Users can shop, compare, and lock in coverage directly through the app, turning what used to be multiple phone calls and websites into a single, streamlined experience. The app is a comprehensive platform that encompasses all aspects of auto financing, from lowering monthly payments to refinancing unfavorable loans. It connects users with vetted lenders, dealers, insurance carriers, and protection programs, ensuring they receive the best possible terms. The inclusion of AI bots throughout the app ensures that customers have access to support and guidance at any time, day or night. "Our new app is a game-changer in the auto finance industry," said Lisa Wynne, spokesperson for Drive Point Exchange. "By leveraging AI technology, and by adding one-tap access to discounted Auto, Home, Renters, and Life insurance, we are able to provide our customers with unparalleled support, savings, and convenience, transforming the way they manage their monthly obligations and long‐term protection." The app's user-friendly interface simplifies the often complex process of auto financing and insurance shopping, making it accessible and understandable for all users. By turning denials into approvals and by surfacing minimum-rate offers across lending and insurance, Drive Point Exchange empowers customers to make informed decisions with confidence, ultimately saving them money and time. Drive Point Exchange's commitment to innovation and customer satisfaction is evident in this latest offering. The app not only enhances the user experience but also reinforces the company's position as a pioneer in the auto finance and personal protection sectors. With the integration of AI, customers can expect a personalized and efficient service that adapts to their individual needs. As the auto finance and insurance landscape continues to evolve, Drive Point Exchange remains at the forefront, dedicated to providing cutting-edge solutions that meet the demands of modern consumers. The launch of this app marks a significant milestone in the company's journey, setting a new standard for customer service, savings, and technological advancement in the industry. About Drive Point Exchange Drive Point Exchange is an auto finance platform that helps drivers lower their monthly payments, refinance bad loans, and unlock better terms through vetted lenders, dealers, and protection programs. It focuses on turning denials into approvals while simplifying the process so customers can understand their options and save money with confidence. Drivepointexchange.us is the APP Press Inquiries Lisa Wynne Support@drivepointexchange.com 18883510782 https://drivepointexchange.com 205 North Michigan Ave Suite 810, Chicago Il 60601
2026-08-13 20:52:43

Maze Therapeutics Announces Appointments to Its Board of Directors
Paula Johnson, M.D., M.P.H., and Sophie Kornowski, Pharm.D., M.B.A., join Maze’s Board of Directors, adding to the Company’s deep bench of clinical and industry experience SOUTH SAN FRANCISCO, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic diseases, today announced the appointments of Paula Johnson, M.D., M.P.H., and Sophie Kornowski, Pharm.D., M.B.A., to its Board of Directors. "We are excited to welcome Paula and Sophie to our Board at this important time for our company. With key progress made in our development programs, we are looking ahead to several important milestones, including additional data from MZE829 in broad AMKD patients in late 2026 or early 2027, initial data from MZE782 in 2027, and additional trial initiations for both molecules next year,” said Jason Coloma, Ph.D., chief executive officer of Maze. "As we continue to advance Maze’s pipeline toward late-stage clinical development and pre-commercial planning, both Paula and Sophie will bring a wealth of clinical and business experience to support our mission to harness the power of genetics to transform the lives of patients.” Dr. Johnson brings over 30 years of clinical and research experience, specializing in cardiology. She has served as President of Wellesley College since 2016 and currently serves on the Board of Directors of Johnson & Johnson (J&J). Previously, Dr. Johnson founded and served as the inaugural Executive Director of the Connors Center for Women’s Health and Gender Biology at Brigham and Women’s Hospital from 2002 to 2016, and served as the Chief of the Division of Women’s Health at Brigham and Women’s Hospital from 2002 to 2016. She previously served as a Clinical Epidemiologist at Brigham and Women’s Hospital, as a Professor of Medicine at Harvard Medical School, and as Professor of Epidemiology at the Harvard School of Public Health. She holds an M.D. from Harvard Medical School, an M.P.H. from the Harvard T.H. Chan School of Public Health, and an A.B. from Harvard. Dr. Kornowski joins Maze’s Board of Directors with more than 35 years of biopharmaceutical leadership experience, most recently serving as Chief Executive Officer of Boston Pharmaceuticals beginning in 2022, focusing the company’s pipeline on candidates for liver disease and leading the company to its acquisition by GlaxoSmithKline (GSK). Previously, she served as a Senior Partner at Gurnet Point Capital. Dr. Kornowski was Executive Vice-President of Roche Partnering and a member of the Extended Corporate Executive Committee of F. Hoffmann-La Roche AG and a board member of Chugai Pharmaceuticals. In that role, she led partnering and M&A strategy across early-stage compounds, late-stage assets, and technology-driven biotech companies, working closely with R&D and Commercial teams at Roche and Genentech. Earlier in her career, she held several commercial leadership roles across geographies in leading innovative pharmaceutical and diagnostic companies in France, Israel, and the U.S., notably at Roche and Merck & Co. She holds a Pharm.D. from Paris Descartes University and an M.B.A. from the University of Chicago Booth School of Business. About Maze Therapeutics Maze Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel small molecule precision medicines for patients with kidney and metabolic diseases. Guided by its CompassTM platform, Maze pursues genetically validated targets by integrating variant discovery and functionalization to discover and advance small molecule programs with first- or best-in-class potential. Maze’s pipeline is led by MZE829, a dual-mechanism APOL1 inhibitor in Phase 2 development for APOL1-mediated kidney disease (AMKD), and MZE782, a SLC6A19 inhibitor in Phase 2 development with the potential to treat both phenylketonuria (PKU) and chronic kidney disease (CKD). Maze is headquartered in South San Francisco. For more information, please visit mazetx.com, or follow Maze on LinkedIn and X. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the "safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect the current beliefs and expectations of management. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including, without limitation, statements concerning the company’s future plans and prospects, any expectations regarding the safety or efficacy of MZE829, MZE782 and other candidates under development, the ability of MZE829 to treat AMKD or other indications, the ability of MZE782 to treat PKU, CKD or other indications, the planned timing of the company’s clinical trials, data results and further development of MZE829, MZE782 and other therapeutic candidates, and the company’s ability to advance its pipeline towards late-stage clinical development. In addition, when or if used in this press release, the words "may,” "could,” "should,” "anticipate,” "believe,” "estimate,” "expect,” "intend,” "plan,” "will,” "predict” and similar expressions and their variants, as they relate to the company may identify forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Although the company believes the expectations reflected in such forward-looking statements are reasonable, the company can give no assurance that such expectations will prove to be correct. Readers are cautioned that actual results, levels of activity, safety, performance or events and circumstances could differ materially from those expressed or implied in the company’s forward-looking statements due to a variety of factors, including risks and uncertainties related to the company’s ability to advance MZE829, MZE782 and its other therapeutic candidates, obtain regulatory approval of and ultimately commercialize the company’s therapeutic candidates, the timing and results of preclinical studies and clinical trials, the company’s ability to fund development activities and achieve development goals, its ability to protect its intellectual property, general business and economic conditions, and risks related to the impact on its business of macroeconomic conditions, including inflation, volatile interest rates, tariffs, instability in the global banking sector, and public health crises. Further information on potential risk factors that could affect the company’s business and its financial results is detailed under the heading "Risk Factors” included in the documents the company files from time to time with the U.S. Securities and Exchange Commission, including the company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Accordingly, readers are cautioned not to place undue reliance on these forward-looking statements. These forward-looking statements speak only as of the date of this press release and the company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date hereof. IR/Corporate Contact: Argot Partners maze@argotpartners.com Media Contact: Amanda Lazaro, 1AB Media amanda@1ABMedia.com
2026-08-13 20:52:33

Sunnyside Medicare Expands Free Plan Comparisons as Annual Changes Confront Michigan Seniors
AUBURN HILLS, MI, Aug. 13, 2026 (GLOBE NEWSWIRE) -- AUBURN HILLS, MI - August 13, 2026 - Sunnyside Medicare, an independent Medicare agency serving communities across Michigan, is expanding its no-cost plan comparison services in response to a growing number of annual plan changes that leave many seniors facing higher premiums, network restrictions, or unexpected coverage gaps. As the range of available Medicare options continues to multiply each year, the agency's licensed brokers are focusing on side-by-side reviews that account for individual doctors, prescriptions, and real out-of-pocket costs. Each year, insurance carriers adjust their Medicare plans, altering provider networks, drug formularies, and cost structures. These annual changes can quietly affect thousands of beneficiaries who keep the same plan without reviewing how the updates apply to their situation. Sunnyside Medicare aims to address that gap by offering patient, no-pressure guidance that helps individuals understand what has changed and how it affects their coverage. The agency's comparison process allows beneficiaries to review plans from many major carriers in one place. Individuals can weigh how different options handle their current physicians, ongoing prescriptions, and anticipated costs before deciding on next steps. The service is designed to help beneficiaries avoid common enrollment mistakes, such as overlooking a dropped medication from a formulary or failing to confirm that a preferred doctor remains in network. Sonny Gurney, owner of Sunnyside Medicare, said the emphasis on details separates a routine sign-up from an informed decision. "Many people renew the same plan without realizing that the network or drug list shifted underneath them," Gurney said. "A comparison that starts with a person's actual doctors and medications tends to surface those changes early, before they turn into a surprise bill or a denied prescription." Beyond the initial comparison, the agency provides ongoing support after enrollment. Brokers revisit each client's coverage during annual changes and at other life events that can affect eligibility or costs. Sonny Gurney, owner of Sunnyside Medicare, said that continuity matters as much as the first review. "Medicare is not a one-time decision," Gurney said. "Plans change, health needs change, and staying informed year over year is what protects a person's access to care and their budget." The agency's services cover consultation, application assistance, plan comparison, and enrollment help. Consultations are structured to explain coverage options in plain terms, while application and enrollment support walks individuals through timing, eligibility, and the steps required to complete the process. The approach is intended to remain straightforward and free of pressure at each stage. Michigan seniors approaching eligibility or reviewing existing coverage during annual enrollment periods represent the primary focus of the expanded effort. By centering the process on the specifics of each person's care, Sunnyside Medicare seeks to reduce the confusion that often accompanies a crowded field of plan choices. https://www.youtube.com/watch?v=T4-un-roBPo Sunnyside Medicare is a Medicare agency based in Michigan that helps individuals navigate Medicare through consultation, application assistance, plan comparison, and enrollment support. Working with many major carriers, the agency provides guidance from licensed agents and ongoing service through annual and life changes. It has earned a 5-star rating from communities across Michigan for its personalized approach. ### For more information about Sunnyside Medicare, contact the company here: Sunnyside Medicare Sonny (248) 277-5948 info@sunnysidemedicare.com Sunnyside Medicare 691 N Squirrel Rd # 165 Auburn Hills, MI 48326, United States CONTACT: Sonny
2026-08-13 20:52:30

zSpace Reports Second Quarter 2026 Financial Results
Margin Expansion Drives Profitability; Strategic Alternatives Review Remains Ongoing SAN JOSE, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- zSpace, Inc. (OTC: ZSPC) ("zSpace” or the "Company”), a leading provider of augmented and virtual reality (AR/VR) solutions for education and workforce development, is announcing its financial results for the three and six months ended June 30, 2026. "Our second quarter results reflect the impact of the actions our management team has taken across the business, which drove net income of $0.3 million this quarter compared to a net loss of $6.1 million a year ago - even as our core K-12 markets continue to work through funding and macro disruption," said Paul Kellenberger, CEO of zSpace. "Revenue was $5.4 million, compared to $7.5 million in the prior year, though we are encouraged by early signs that demand is beginning to normalize as customers resume purchasing decisions that were paused earlier in the year. Underlying this improvement in profitability is a structural shift in our business: gross margin expanded 1,380 basis points year-over-year to 56%, driven by the continued move toward higher-margin software and services revenue, growth in Company-owned software content, and a leaner hardware cost profile. These are efforts our team has been driving for some time and that we believe should continue to support margins as they take fuller effect. Results this quarter also benefited from actions to strengthen our balance sheet, including a one-time gain recognized in connection with converting a portion of outstanding debt to equity, which will not recur in future periods. Taken together, we believe these results demonstrate our ability to execute with discipline and control what we can control, even in a K-12 environment that remains uneven. At the same time, we recognize that our current valuation does not fully reflect the strength of our platform, which is why the Board continues its ongoing formal review of strategic alternatives to ensure we are doing everything we can to maximize long-term value for our shareholders.” Second Quarter 2026 Financial Summary vs. Same Year-Ago Period Revenue of $5.4 million vs. $7.5 millionSoftware and services comprised 47% of revenue vs. 42%Gross margin of 56% vs. 43%Net income of $0.3 million vs. net loss of ($6.1) millionAdjusted EBITDA of ($0.9) million vs. ($4.5) millionRecent Business HighlightszSpace announced that its technology powered breakthrough 3D thyroid reconstruction research in Italy, with partner L’ABCD Edutainment using the zSpace platform to visualize AI-generated 3D anatomical models from 2D ultrasound images.zSpace appointed VR Expert as its first master reseller in Europe, expanding distribution of its AI-enhanced immersive learning platform to schools and institutions across the continent and accelerating adoption in STEM, CTE and workforce preparation.zSpace eliminated over $12 million in debt through agreements with its lenders, converting outstanding principal and interest into equity to strengthen the Company’s balance sheet and support long-term growth.zSpace highlighted its partnership with the Challenger Learning Center of Northeast Alabama, marking the opening of an immersive STEM facility featuring NASA-style mission simulations and zSpace laptops across a 12-county region.Second Quarter 2026 Financial Results Revenue in the second quarter of 2026 was $5.4 million compared to $7.5 million in the second quarter of 2025. The decrease was driven by orders for EMEA that were delayed and returned as a result of the Iran war. Gross margins increased 1,380 basis points to 56% compared to the second quarter of 2025. The increase was driven by improvements in hardware cost profiles, richer software mix of revenue, and more Company-owned software content. Annualized Contract Value ("ACV”) of renewable software at June 30, 2026, was $9.4 million, representing a 13% decrease compared to a year ago. Net Dollar Revenue Retention (NDRR) at June 30, 2026, was 66% for customers with over $50,000 of ACV, compared with the same customers as of June 30, 2025. Excluding the impact of two key customer losses in the third quarter of 2025, normalized NDRR was 83%. Bookings in the second quarter of 2026 were $6.0 million, down 14% year-over-year. The backlog of unfulfilled orders as of June 30, 2026 was $3.8 million. Operating expenses, excluding stock-based compensation expense, in the second quarter of 2026 were $4.0 million compared to $7.7 million in the second quarter of 2025. Net income in the second quarter of 2026 was $0.3 million compared to a net loss of ($6.1) million in the second quarter of 2025. Adjusted EBITDA loss was ($0.9) million compared to ($4.5) million in the second quarter of 2025. Balance Sheet As of June 30, 2026, zSpace had approximately $0.9 million in cash, cash equivalents and restricted cash, compared to $1.4 million in cash, cash equivalents and restricted cash as of June 30, 2025. About zSpace zSpace, Inc. (OTC: ZSPC) delivers innovative augmented and virtual reality (AR/VR) experiences that drive achievement in STEM, CTE, and career readiness programs. Trusted by over 3,500 school districts, technical centers, community colleges, and universities, zSpace enables hands-on "learning by doing" experiences proven to improve engagement and student outcomes. Headquartered in San Jose, California, zSpace holds more than 80 patents, with research published in the Journal of Computer Assisted Learning (2021) validating the impact of 3D virtual reality technologies on student knowledge gains. Key Metric Definitions We monitor the following key metrics to help us evaluate our business, identify trends affecting our business, formulate business plans and make strategic decisions. The calculation of the key metrics discussed below may differ significantly from other similarly titled metrics used by other companies, analysts, investors and other industry participants. We reference bookings in this press release, which is an internal operational measure of the business. Bookings represent customer orders that have hardware, software and service components. Bookings indicate future revenue, which lags based on product shipping date, monthly recognition of certain subscription revenue and service delivery completion. We reference Annualized Contract Value (ACV) in this press release, which is an internal operational measure of the business. To monitor our ability to retain and grow our customer base for our software we monitor the annualized contract value of active renewable software licenses. We reference Net Dollar Revenue Retention (NDRR) in this press release, which is an internal operational measure of the business. We calculate our NDRR as of a given period end by starting with the ACV from all customers with contracts of at least $50,000 of ACV as of 12 months prior to such period end ("Prior Period ACV”) and calculating the ACV from these same customers as of the current period end ("Current Period ACV”). Current Period ACV includes any upsells and is net of contraction or attrition over the trailing 12 months but excludes revenue from new customers in the current period. We then divide the total Current Period ACV by the total Prior Period ACV to arrive at our NDRR. We reference Adjusted EBITDA in this press release, which we calculate Adjusted EBITDA as GAAP net income (loss) adjusted for interest expense, depreciation and amortization expense, income tax expense, offering costs related to financing activities, stock-based compensation, gain on extinguishment of debt, change in fair value of convertible debt, and the change in fair value of Series P and P 2 Preferred Stock liability. We believe this measure provides our management and investors with consistency and comparability with our past financial performance and is an important indicator of the performance and profitability of our business. Bookings, ACV, NDRR, and Adjusted EBITDA are non-GAAP financial measures (U.S. generally accepted accounting principles). These non-GAAP measures may not be comparable to similarly titled measures being disclosed by other companies. Management believes that presenting these non-GAAP financial measures provide investors with additional analytical tools which are useful in evaluating our operating results and the ongoing performance of our underlying businesses because they (i) provide meaningful supplemental information regarding financial performance by excluding impact of one-time items and other items affecting comparability between periods, (ii) permit investors to view performance using the same tools that management uses to budget, make operating and strategic decisions, and evaluate our core operating performance across periods, and (iii) otherwise provide supplemental information that may be useful to investors in evaluating our financial results. We do not, nor do we suggest that investors, consider such non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Forward-Looking Statements Certain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the stabilization of the education market, the long-term potential of our business, and ability to execute with discipline. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including the uncertainties related to market conditions and other factors discussed in the "Risk Factors" section of the Company's filings with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and zSpace, Inc. specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. FINANCIAL TABLES - INCOME STATEMENT, BALANCE SHEET AND EBITDA 3 Months Ended June 30, 6 Months Ended June 30, 2026 2025 2026 2025Revenue $5,396 $7,459 $10,647 $14,218 Cost of goods sold 2,352 4,285 4,816 7,838 Gross profit 3,044 3,174 5,831 6,380 Gross profit % 56.4% 42.6% 54.8% 44.9%Operating expenses: Research and development 814 1,274 1,806 2,369 Selling and marketing 2,161 3,948 4,575 7,950 General and administrative 3,804 4,281 7,118 7,774 Gain from settlement of vendor claims (1,198) - (1,198) - Total operating expenses 5,581 9,503 12,301 18,093 Loss from operations (2,537) (6,329) (6,470) (11,713)Other (expense) income: Interest expense (241) (301) (585) (803)Other income, net 63 14 169 70 Gain on extinguishment of convertible and other debt 4,052 - 4,052 - (Loss) gain on change in fair value of Series P Preferred Stock Liability (34) - 207 - (Loss) gain on change in fair value of convertible debt (1,006) 525 (3,634) 525 Net income (loss) before income taxes 297 (6,091) (6,261) (11,921)Income tax expense 9 11 9 13 Net income (loss) $288 $(6,102) $(6,270) $(11,934) BALANCE SHEET June 30, June 30, December 31, 2026 2025 2025Selected Balance Sheet Information: Cash, cash equivalents and restricted cash $856 $1,390 $1,021 Accounts receivable, net $2,609 $4,643 $1,438 Inventory, net $1,996 $2,596 $2,404 Total Assets $8,282 $12,137 $7,586 Accounts payable & accrued expenses $6,288 $10,575 $7,784 Convertible, Series P and P 2, other debt and accrued interest $12,091 $19,963 $20,079 Total liabilities $21,467 $34,433 $30,094 Stockholders' deficit $(13,185) $(22,296) $(22,508)Total Liabilities and Stockholders' Deficit $8,282 $12,137 $7,586 Three Months Ended June 30, Six Months Ended June 30, 2026 2025 2026 2025GAAP Net Income (Loss) $288 $(6,102) $(6,270) $(11,934)Add back (deduct): Interest expense 241 301 585 803 Depreciation and amortization 3 2 6 3 Income tax expense 9 11 9
2026-08-13 20:52:29

ContextLogic Holdings Inc. Reports Second-Quarter 2026 Financial Results
OAKLAND, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB: LOGC) ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the quarter and six months ended June 30, 2026. Basis of Presentation ContextLogic completed the acquisition of US Salt Parent Holdings, LLC and all its majority or wholly owned subsidiaries ("US Salt") on February 26, 2026 (the "US Salt Acquisition"). As a result of the significance of the relative operations acquired in the US Salt Acquisition, US Salt is reflected as the Predecessor to the combined entity for financial statement purposes. Accordingly, all periods presented through the closing date of the US Salt Acquisition, February 26, 2026, reflect the historical balances and results of US Salt ("Predecessor"). Periods presented after the closing of the US Salt Acquisition reflect the accounts of the Company and its majority and wholly owned subsidiaries, including US Salt ("Successor"). To provide comparable period-over-period information, the Company also presents "Combined" results, a non-GAAP measure that aggregates the Predecessor and Successor periods. Note that "CLHI Corporate" refers to public company and parent-level items of ContextLogic Holdings Inc., distinct and separate from the operating results of US Salt. Second Quarter 2026 Results Revenue: Revenue for the second quarter of 2026 was $33.6 million, essentially flat compared to $33.8 million in the second quarter of 2025. We experienced lower sales volume in the quarter, partially offset by higher average sales prices driven by price increases and a favorable shift in product mix. The average sales price in the second quarter of 2026 was 7.7% higher than that of the prior-year quarter, which generated approximately $2.4 million of additional revenue. Overall volume during the second quarter of 2026 decreased 8.0%, compared with the second quarter of 2025, resulting in an approximately $2.6 million reduction in revenue. The decrease in volume was primarily attributable to a planned maintenance shutdown in the quarter that was not performed in the prior-year and transportation constraints related to limited trucking availability that limited shipments during the quarter. Net Income: Net loss for the second quarter of 2026 was $6.3 million, a decrease of $11.0 million compared to net income of $4.7 million in the second quarter of 2025. The quarterly net loss was driven by CLHI Corporate costs, including transaction and general and administrative expenses incurred at the parent level, and increased intangible asset amortization expenses related to acquisition accounting. Adjusted EBITDA: Non-GAAP Adjusted EBITDA for the second quarter ended June 30, 2026 was $10.8 million, a decrease of $3.2 million compared to $14.0 million in the prior year's second quarter. The decline reflects approximately $2.5 million of CLHI Corporate costs that were not present in the comparable period. Free Cash Flow: Cash flow from operations, net of capital expenditures, was ($21.6) million for the Combined first six months of 2026 as compared to $7.9 million in the prior year's first six months. The decline reflects $22.6 million of transaction expenses related to the US Salt Acquisition and searching for other potential acquisitions. Outstanding Equity: For the three-month period ended June 30, 2026 (Successor), there were 101.6 million weighted average units outstanding at ContextLogic Holdings, LLC, the Company's consolidated subsidiary that holds the operating businesses. Of these, 45.7 million units were held by ContextLogic Holdings Inc. (equivalent to the weighted average common shares outstanding of the public company), and the remaining 55.9 million units were held by other holders of LLC units. Key Financial Successor Predecessor Three Months Ended June 30, 2026 Three Months Ended June 30, 2025 $ Change (in millions) (in millions) Net Sales $33.6 $33.8 $(0.2)Gross Profit 12.5 13.7 (1.2)Selling Expense 1.0 1.0 - General and Administrative 11.7 2.4 9.3 Transaction Expenses 1.8 0.2 1.6 Net (Loss) Income (6.3) 4.7 (11.0) EBITDA1 $8.0 $13.7 $(5.7)Adjusted EBITDA1 10.8 14.0 (3.2)EBITDA and Adjusted EBITDA are non-GAAP financial measures. For definitions of EBITDA and Adjusted EBITDA and a reconciliation to the most directly comparable financial measures calculated in accordance with GAAP, see the schedule titled "Reconciliation of Net Income to EBITDA and Adjusted EBITDA." Successor Predecessor Three Months Ended June 30, 2026 Three Months Ended June 30, 2025Supplemental Disclosure Items1: (in millions) (in millions)CLHI Corporate G&A $2.5 $-CLHI Corporate Transaction Expenses 1.3 -CLHI Corporate Depreciation & Amortization - -CLHI Corporate Tax Expense - -CLHI Adjusting Expense Items for Adjusted EBITDA2 1.4 -CLHI Corporate Expenses are expenses incurred at the corporate level.This amount represents expenses incurred at the corporate level that are included in the adjustments for Adjusted EBITDA and consist of $1.3 million of transaction expenses and $0.1 million of stock-based compensation (where stock-based compensation is included in G&A in the above table). Successor Equity Ownership Information: (shares and units in thousands) Three Months Ended June 30, 2026 ContextLogic Weighted Average Common Shares Outstanding 45,737 ContextLogic Holdings, LLC Weighted Average Units Outstanding 101,604 Question & Answer The Company invites stockholders and interested parties to submit questions regarding its second quarter 2026 financial results and operating performance. Questions may be submitted via email to ir@contextlogic.com by August 17, 2026. The Company plans to prepare and share responses on its website at www.contextlogic.com by August 21, 2026. About ContextLogic Holdings Inc. ContextLogic Holdings Inc. is a publicly traded business ownership platform established to own a collection of niche, competitively advantaged, long-duration businesses. Each business operates with meaningful autonomy under world-class management teams whose incentives are tightly aligned with those of their shareholders, supported by a governance structure that creates direct accountability between operators and owners. For more information about ContextLogic, please visit www.contextlogic.com. Forward-Looking Statements This news release contains forward-looking statements within the meaning of the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact could be deemed forward-looking, including, but not limited to, developing our pipeline of potential future acquisitions. In some cases, forward-looking statements can be identified by terms such as "anticipates," "believes," "could," "estimates," "expects," "foresees," "forecasts," "goals," "guidance," "intends," "may," "might," "outlook," "plans," "potential," "predicts," "projects," "seeks," "should," "targets," "will," "would" or similar expressions and the negatives of those terms. These forward-looking statements are subject to risks, uncertainties, and assumptions. If the risks materialize or assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. Important factors, risks and uncertainties that could cause actual results to differ materially from those forward-looking statements include but are not limited to: statements regarding the US Salt Acquisition, the strategic alternatives considered by the Company's board of directors, including the decisions taken thereto; future financial performance; future liquidity and operating expenditures; financial condition and results of operations; enforceability of transfer restrictions and occurrence of an ownership change with the result that ContextLogic's ability to use its net operating losses could be severely limited; future legislation resulting in ContextLogic being unable to realize the benefits of the tax attributes; ContextLogic's ability to make use of the existing benefits of the tax attributes because ContextLogic may not generate taxable income; the IRS's possible challenge of the amount of the tax attributes or claim that ContextLogic experienced an ownership change, which could reduce the amount of tax attributes that ContextLogic could use; risks related to any future acquisition of a business or assets; currently pending or future litigation; risks if we are deemed to be an investment company under the Investment Company Act of 1940; the effect of new accounting pronouncements; competitive changes in the marketplace and other characterizations of future events or circumstances; and the other important factors discussed in our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q or Current Reports on Form 8-K. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. Further information on these and additional risks that could affect ContextLogic's results is included in its filings with the Securities and Exchange Commission (the "SEC"), including the Annual Report on Form 10-K for the year ended December 31, 2025, the Quarterly Report on Form 10-Q for the periods ended March 31, 2026 and June 30, 2026 and other reports that ContextLogic files with the SEC from time to time, which could cause actual results to vary from expectations. Any forward-looking statement made by ContextLogic in this news release speaks only as of the day on which ContextLogic makes it. ContextLogic assumes no obligation to, and does not currently intend to, update any such forward-looking statements after the date of this release. ContextLogic Holdings Inc. Condensed Consolidated Balance Sheet Data ($ in millions) (unaudited) Successor Predecessor As of June 30, As of December 31, 2026 2025 (in millions) (in millions) Assets Current assets 39.7 34.8 Property, plant and equipment, net 395.6 321.4 Goodwill 148.0 28.1 Intangibles, net 378.3 16.8 Other 6.6 6.7 Total assets $968.2 $407.8 Liabilities, Members' Equity, and Stockholders' Equity Current liabilities 21.2 17.9 Long-term debt, net of current maturities 209.4 203.1 Other 2.1 1.6 Total liabilities 232.7 222.6 Total members' equity and stockholders' equity 735.5 185.2 Total liabilities, members' equity, and stockholders' equity $968.2 $407.8 ContextLogic Holdings Inc. Condensed Consolidated Statements of Operations ($ in millions, units and shares in thousands, except per unit and share data) (unaudited) Successor Predecessor Three Months Ended June 30, 2026 Period from February 27, 2026 to June 30, 2026 Period from January 1, 2026 to February 26, 2026 Three Months Ended June 30, 2025 Six Months Ended June 30, 2025 (in millions) (in millions) (in millions) (in millions) (in millions) Net sales $33.6 $45.7 $20.3 $33.8 $66.1 Cost of sales 21.1 29.4 13.2 20.1 40.5 Gross profit 12.5 16.3 7.1 13.7 25.6 Operating expenses: Selling expense 1.0 1.4 0.7 1.0 2.0 General and administrative 11.7 19.2 1.6 2.4 5.0 Transaction expenses 1.8 22.5 0.1 0.2 0.2 Total operating expenses 14.5 43.1 2.4 3.6 7.2 (Loss) income from operations (2.0) (26.8) 4.7
2026-08-13 20:52:24

Golden Jewelers Strengthens Trusted Cash-for-Gold and Jewelry Buying Services Across South Jersey and Philadelphia
Golden Jewelers helps customers across South Jersey and the Philadelphia area sell gold, jewelry, diamonds, coins, and precious metals through transparent evaluations and prompt cash payments. Golden Jewelers Strengthens Trusted Cash-for-Gold and Jewelry Buying Services Across South Jersey and Philadelphia Golden Jewelers helps customers across South Jersey and the Philadelphia area sell gold, jewelry, diamonds, coins, and precious metals through transparent evaluations and prompt cash payments. Cinnaminson, NJ , Aug. 13, 2026 (GLOBE NEWSWIRE) -- Golden Jewelers - Cash For Gold, a family-owned precious metals and jewelry buyer operating for over 30 years, continues expanding its reach throughout South Jersey and the Philadelphia region. Based in Cinnaminson, New Jersey, the business provides free, transparent evaluations for gold, silver, diamonds, coins, watches, bullion, and estate jewelry. Operating seven days a week without appointment requirements, Golden Jewelers delivers immediate cash offers based on current market conditions and fair appraisals. Golden Jewelers continues strengthening its position as a trusted cash-for-gold and jewelry buyer serving customers across South Jersey and the Philadelphia area. Through transparent evaluations, immediate cash offers, and a customer-first approach, the family-owned business helps individuals confidently sell precious metals, jewelry, diamonds, coins, watches, bullion, and estate collections. Golden Jewelers - Cash For Gold With more than three decades of jewelry industry experience, Golden Jewelers has built a reputation for honest dealings and customer-focused service. Cash for Gold in Cinnaminson, Palmyra, Riverton, Delran, Riverside, Moorestown, Pennsauken, Maple Shade, and Cherry Hill represents a commitment to making the selling process safe, convenient, and accessible to residents across the region. Located in The Shoppes at Cinnaminson, Golden Jewelers provides a safe and comfortable environment where customers can sell with confidence. Just minutes from Philadelphia via nearby bridges, the store offers convenient access for customers throughout Burlington, Camden, Gloucester, and Philadelphia Counties. Its extended hours eliminate barriers that often prevent customers from obtaining fair valuations for their valuables. The Gold Buyer Cinnaminson, NJ store conducts every appraisal using transparent methods that account for current market fluctuations. Customers receive detailed explanations of how evaluations are determined, with no hidden fees or surprise deductions from final offers. The cash for jewelry services encompass everything from designer pieces and vintage collections to broken items and single stones, recognizing that valuable jewelry takes many forms. "At Golden Jewelers, our goal is to make selling gold, jewelry, diamonds, coins, and other valuable items a transparent and straightforward experience. We are committed to providing honest evaluations, competitive offers, and personal service to customers throughout South Jersey and the Philadelphia area, while offering a safe, comfortable location where they can sell with confidence," a company spokesperson stated. How Golden Jewelers Helps Customers Maximize Value from Precious Metals and Collections Beyond traditional gold buying, Golden Jewelers accepts a comprehensive range of valuables. Cash for Gold Bullion represents one specialization, catering to investors and collectors looking to convert physical holdings into immediate funds. The business also serves customers seeking to sell gold for cash, recognizing that motivations vary-whether downsizing, managing inheritance, consolidating collections, or addressing immediate financial needs. Cash for Coins adds another dimension to services offered, with dedicated expertise in numismatic evaluation and precious metal composition analysis. Diamonds, watches, bullion, and collectible coins receive the same careful attention as precious metals during every evaluation. Customers throughout South Jersey and the Philadelphia area can have loose diamonds, engagement rings, vintage timepieces, contemporary watches, and coin collections professionally assessed using transparent appraisal methods based on current market conditions. This specialized expertise across multiple asset categories helps ensure customers receive fair, accurate valuations regardless of what they choose to sell. Key Features and Facts Location Coverage: Cinnaminson, Palmyra, Riverton, Delran, Riverside, Moorestown, Pennsauken, Maple Shade, Cherry Hill, Burlington County, Camden County, Gloucester County, Philadelphia County, and surrounding South Jersey and Philadelphia communities.Service Offerings: Gold and precious metals buying, jewelry evaluation, diamond assessment, coin valuation, bullion purchase, watch buying, estate jewelry liquidationCredentials: Over 30 years of jewelry industry experience, family-owned and operated, transparent appraisal methodology based on current market conditionsAvailability: Open seven days a week, no appointment necessary, immediate cash offers for accepted itemsFrequently Asked Questions Q: How does Golden Jewelers determine fair market value for gold and jewelry? A: Every evaluation considers current precious metals market conditions and the specific characteristics of each item. The company applies transparent methodology with no hidden deductions, providing customers with detailed explanations before making offers. Q: What should customers bring when visiting for evaluations? A: Customers can bring any items they wish to evaluate-gold pieces, jewelry collections, diamonds, coins, watches, bullion, or estate items. No preparation is needed; the Cinnaminson location handles the complete assessment process. Q: How quickly can Golden Jewelers provide payment for accepted items? A: Immediate cash offers are provided following evaluations, with payment issued once customers accept the terms. This same-day service eliminates extended waiting periods common with alternative liquidation methods. Q: Do Golden Jewelers accept items with damage or imperfections? A: Yes, the company evaluates items regardless of condition, including broken jewelry, bent coins, damaged watches, and worn pieces. Precious metal content determines value even when items lack cosmetic appeal. Q: What areas beyond Cinnaminson do Golden Jewelers serve? A: Golden Jewelers welcomes customers from throughout South Jersey and the Philadelphia region, including residents from Palmyra, Riverton, Delran, Riverside, Moorestown, Pennsauken, Maple Shade, Cherry Hill, Burlington County, Camden County, Gloucester County, and Philadelphia County. Located in The Shoppes at Cinnaminson and just minutes from Philadelphia via nearby bridges, the store provides a safe, convenient location for customers across the region. Visit https://cashforgolden.com/ to learn more about services and current market information. About Golden Jewelers - Cash For Gold: Golden Jewelers operates as a family-owned precious metals and jewelry buyer with over 30 years of jewelry industry experience serving South Jersey and the Philadelphia area. The business specializes in transparent, free evaluations of gold, silver, diamonds, coins, watches, platinum, bullion, estate jewelry, and other valuable items, with immediate cash offers based on current market conditions. Located in Cinnaminson, New Jersey, Golden Jewelers operates seven days a week without appointment requirements, prioritizing first-class customer service and fair, transparent transactions. Visit cashforgolden.com for additional information. ### Media Contact: Golden Jewelers - Cash For Gold 141 US-130, Suite H, Cinnaminson, NJ 08077 (856) 786-8660 cashforgolden.com Disclaimer: The contents of this press release are for informational purposes only. You should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this press release constitutes a consultation or a solicitation for investment or the purchase or sale of any financial asset. Any investment decision should be made after consulting with a professional about your specific circumstances. The information provided in this press release does not constitute advice or investment opinion, and it should not be relied upon as such. It should not be considered a solicitation to buy or an offer to sell a security. It does not take into account any reader's particular investment objectives, financial situations, or needs. Readers should not consider it as financial advice and should consult with their financial advisor before making any investment decisions. Neither the distribution company nor its partners are responsible for any decision made on the basis of this press release. Any decision based on this press release should be made after consulting with a professional. The source of this press release, InvestingInGold.com, must be contacted for any queries. Attachment Golden Jewelers Strengthens Trusted Cash-for-Gold and Jewelry Buying Services Across South Jersey and Philadelphia
2026-08-13 20:52:07

Intermap Reports Second Quarter 2026 Results
Announced definitive agreement to acquire PCI Geomatics, creating a vertically integrated geospatial intelligence platform, scheduled to close in Q3 2026 Value-added Data revenue more than doubled while Software and Solutions prepaid revenue grew 35% Conference call today at 5:00 pm ET to discuss results and provide a business update DENVER, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Intermap Technologies, (TSX: IMP; OTCQB: ITMSF) ("Intermap” or the "Company”) a global leader in geospatial intelligence powered by proprietary 3D data and AI-driven analytics, today reported second quarter 2026 financial results and continued execution of its long-term growth strategy, including the acquisition of PCI Geomatics. Following the quarter, Intermap announced a definitive agreement to acquire PCI Geomatics, a global leader in satellite and aerial image processing technology. The acquisition expands Intermap’s geospatial intelligence platform, with industry-leading image processing, cloud-native micro services, APIs and edge-processing capabilities that support more than 500 satellites and thousands of production workflows. The transaction is expected to close by the end of September 2026, subject to PCI shareholder approval and customary closing conditions. "During the second quarter, Intermap took an important strategic step with the announcement of our acquisition of PCI Geomatics,” said Patrick A. Blott, Chairman and Chief Executive Officer of Intermap Technologies. "The transaction combines commercial leaders in elevation and image processing, leveraging our data and AI platform in the commercial space segment, while expanding product breadth with distributed edge-enabled micro services.” "We continued investing in our people, technology and infrastructure to support government and commercial growth,” Mr. Blott continued. "Acquisition Services revenue reflected timing of follow-on contract awards in Indonesia, which remain delayed, impacting year on year comparisons. However, Intermap confirmed to the Indonesian government its ongoing commitment to a successful program and international tendering process, which enjoys active support and engagement from the World Bank.” Business Highlights Announced a definitive agreement to acquire PCI Geomatics, creating a vertically integrated geospatial intelligence platform spanning data collection, image processing, orthorectification, 3D DEM terrain intelligence and AI-powered analyticsExpanded Intermap’s commercial offering with PCI’s satellite and aerial image processing technologies, cloud-native microservices, APIs and edge-processing capabilitiesGrew commercial risk business with the addition of property valuation and multi-peril analytics, adopted by eight specialty line insurers within the Czech insurance associationContinued investing in personnel, aircraft, radar systems and processing capabilities to support national-scale government programs and commercial growthAdvanced government opportunities across Southeast Asia, North America, South America and the Middle East, while supporting follow-on opportunities in IndonesiaContinued expanding commercial applications built on Intermap’s proprietary 3D data foundation, including AI-powered insurance analytics, automated orthorectification and enterprise geospatial intelligence solutionsFinancial Highlights Revenue for the second quarter was $2.0 million compared with $3.0 million in the second quarter of 2025. Revenue for the first six months of 2026 was $3.4 million compared with $7.3 million during the same period last year. The expected declines reflect the absence of Acquisition Services revenue during the period due to the timing of follow-on contract awards in Indonesia. Value-added Data revenue increased to $0.7 million during the quarter from $0.3 million in the prior year. Software and Solutions revenue remained steady at $1.3 million, while software prepaid revenue grew 35%. Net loss for the second quarter was $2.1 million, or $0.03 per share, compared with a net loss of $0.8 million, or $0.02 per share, in the second quarter of 2025. Adjusted EBITDA was negative $1.4 million compared with negative $0.3 million in the prior-year period. Results reflect the absence of Acquisition Services revenue while Intermap participates in the Indonesian tendering process and continued investment in personnel and infrastructure to support growth. The Company invested approximately $2.2 million year-to-date to upgrade its platform, including airborne, sensor, processing and AI technologies. Outlook Intermap’s underlying business outlook remains unchanged, with the timing of the Indonesia opportunity continuing to be the principal variable affecting 2026 results. The Company remains confident in its long-term growth prospects and the strength of its government and commercial opportunities. Intermap expects to provide updated financial guidance following the closing of the PCI transaction, reflecting the financial profile and outlook of the combined company. Intermap is focused on completing the acquisition of PCI Geomatics, expanding its vertically integrated geospatial intelligence platform, integrating PCI’s technologies and commercial capabilities, converting government opportunities into awarded contracts and expanding recurring commercial revenue. The Company’s pipeline continues to grow, while it maintains deployment readiness for Indonesia, pursuant to its binding commitments there, and advances AI-powered applications across its defense, insurance, commercial space and infrastructure markets. Intermap believes its strengthened balance sheet, proprietary technology platform and expanded commercial capabilities position the Company to pursue larger opportunities and create long-term shareholder value. Quarterly Filing The Company’s condensed consolidated interim financial statements for the three and six months ended June 30, 2026, together with Management’s Discussion and Analysis and related management certifications, will be filed on SEDAR+ at https://www.sedarplus.ca and on the SEC’s EDGAR website at https://www.sec.gov. Adjusted EBITDA is a non-GAAP measure. EBITDA consists of net loss and excludes financing costs, financing income, taxes, depreciation and amortization. Adjusted EBITDA also excludes share-based compensation and foreign currency translation. See "Reconciliation of Non-GAAP Measures” in the Company’s Management’s Discussion and Analysis filed on SEDAR+ and EDGAR. Conference Call Details Intermap’s Chairman and Chief Executive Officer Patrick A. Blott and Executive Vice President and Chief Financial Officer Jennifer Bakken will host a live webinar today to review the results, provide a business update and answer investor questions. Intermap invites shareholders, analysts, investors, media representatives and other stakeholders to attend. DATEThursday, August 13, 2026TIME5:00 pm ETWEBCASTRegister Learn more about Intermap here. Intermap Reader Advisory Certain information provided in this news release constitutes forward-looking statements within the meaning of applicable securities laws. These statements include, but are not limited to, statements regarding the proposed acquisition of PCI Geomatics, the expected timing and completion of the transaction, the anticipated benefits of the acquisition, integration plans, the Company’s growth strategy, government contracting opportunities, commercial adoption of its products and services, customer relationships, strategic initiatives and business outlook. The words "anticipate,” "believe,” "continue,” "estimate,” "expect,” "intend,” "plan,” "project,” "will” and similar expressions are intended to identify such forward-looking statements. Forward-looking statements are based on management’s current expectations, estimates and assumptions and are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ from those expressed or implied by such statements. These risks and uncertainties include the Company’s ability to complete the acquisition of PCI Geomatics and satisfy applicable closing conditions, integrate PCI’s operations and technologies, realize anticipated benefits from the acquisition, secure and execute government contracts, manage the timing of procurement and revenue recognition, expand commercial adoption of its products and services, obtain financing on acceptable terms, retain key personnel and respond to competitive, economic, geopolitical and regulatory developments. Additional risks include cash available to fund operations, availability of capital, revenue fluctuations, the nature of government contracts, economic conditions, loss of key customers, retention and availability of executive talent, competing technologies, common share price volatility, loss of proprietary information, application and platform functionality, information technology security, breakdown of strategic alliances and international and political considerations, as well as the risks described in Intermap’s Annual Information Form and other filings with Canadian securities regulators. No assurance can be given that the PCI transaction will be completed on the terms or within the timeframe contemplated, that anticipated benefits will be realized or that government opportunities will result in awarded contracts or recognized revenue. Readers are cautioned not to place undue reliance on forward-looking statements. The forward-looking statements contained in this news release are made as of the date of this news release, and the Company undertakes no obligation to update or revise them except as required by applicable securities laws. About Intermap Technologies Intermap Technologies is a global leader in geospatial intelligence powered by proprietary 3D data and AI-driven analytics. The Company delivers actionable intelligence to government and commercial customers through a portfolio of applications, platforms and solutions that support risk management, infrastructure planning, operational readiness and mission-critical decision-making. Intermap's proprietary 3D data foundation spans more than 300 million square kilometers across over 150 countries and powers intelligence solutions for government, insurance, aviation, telecommunications, transportation, renewable energy, agriculture, natural resources and space markets. Through advanced analytics, automated processing and enterprise-scale data delivery, Intermap helps organizations transform complex geospatial information into decision-ready intelligence. For more information, please visit www.intermap.com or contact: Jennifer Bakken Executive Vice President and CFO CFO@intermap.com +1 (303) 708-0955 Sean Peasgood Investor Relations Sean@SophicCapital.com +1 (647) 260-9266
2026-08-13 20:52:03

New indictment alleges Nick Reiner was lying in wait before killing parents Rob and Michele Reiner
LOS ANGELES — A Los Angeles County grand jury has indicted Nick Reiner on murder charges in the killings of his parents, actor Rob Reiner and Michele Singer Reiner, and adds the allegation that he was lying in wait before attacking them. The grand jury, which had been meeting in secret, returned the indictment on July 20, and it was unsealed Wednesday, when Nick Reiner entered a not guilty plea. The director, actor and Hollywood luminary Rob Reiner and his wife, photographer and producer Michele Singer Reiner, were stabbed to death in their home in the upscale Brentwood section of Los Angeles on Dec. 14. Nick Reiner was arrested hours later and charged two days later. The grand jury indictment is a major step toward trial and allows prosecutors to skip California’s preliminary hearing process, where evidence is publicly aired. The unsealed indictment reveals few new details in a case that has been shrouded in secrecy. But the lying in wait allegation along with other circumstances mean Reiner is elligible for the death penalty. Prosecutors say they haven’t decided whether to seek it.
2026-08-12 19:07:04

WORLD’S BEST STREET FOOD now in phl
Vikings, The Alley brings global street food to Filipino diners with its “100 Best Street Food in the World” menu, featuring flavors from Peru, Morocco, Mexico, Argentina and beyond.
2026-08-12 19:06:15

Calix launches scam protection services for broadband providers

2026-08-12 19:06:10

SEC files civil complaint against Netcapital and individuals

2026-08-12 19:06:09

Chevron names Uriel Oseguera as treasurer, effective November

2026-08-12 19:06:08

Constellium outlook raised to positive by Moody’s on strong results

2026-08-12 19:04:09

Moody’s upgrades Rolls-Royce outlook on strong performance

2026-08-12 19:04:08

Nvidia’s $500 Billion Financing Arrangement Helps Customers Fund GPU Purchases
Market Analysis by covering: NVIDIA Corporation, Super Micro Computer Inc, United States 10-Year, 10 Year Treasury Yield. Read 's Market Analysis on Investing.com PH.
2026-08-12 19:04:00

EU wheat jumps after Ukraine attacks grain terminals in major Russian export port
A futures broker said, “If the fighting persists in the Black Sea with the logistical problems, then it will be pretty bullish for wheat.”
2026-08-12 19:03:23

Doh Kyung Soo takes a ‘Day Off’ in Manila
EXO’s D.O. is bringing his 2026-2027 “DAY OFF” Concert Tour to Manila on 23 January 2027, with a show set at Smart Araneta Coliseum for Filipino fans.
2026-08-12 19:02:26

Azerbaijan, US Discuss Prospects For Advancing Strategic Partnership (PHOTO)
(MENAFN - Trend News Agency) BAKU, Azerbaijan, August 11. Azerbaijan and the United States discussed the prospects for developing their strategic partnership. This was stated in a press statement ...
2026-08-11 10:31:48

Absentee senator-judges? Up to them to explain to public --court spokesperson
Impeachment court spokesperson Regie Tongol on Tuesday said that it is up to the senator-judges to explain their absence from the impeachment trial to the public.
2026-08-11 10:31:10

Govt Asks Meta To Align Content Policies With Indian Laws, Tighten Deepfake Safeguards
(MENAFN - IANS) New Delhi, Aug 11 (IANS) The government has asked Meta to align its content policies and enforcement mechanisms with Indian laws and the country's cultural context, while making it ...
2026-08-11 10:30:41

K'taka: ED Searches Premises Linked To Shivam Associates In Rs 2,110 Cr Fraud Case
(MENAFN - IANS) Belagavi, Aug 11 (IANS) The Directorate of Enforcement (ED), Mangaluru, Karnataka, has conducted search operations at various premises in Belagavi, Chikkodi and Nipani linked to ...
2026-08-11 10:30:38

Bihar: Prashant Kishor Promises Jobs, Better Schools In Bankipur
(MENAFN - IANS) Patna, Aug 11 (IANS) Jan Suraaj Party founder and newly elected Bankipur MLA Prashant Kishor visited his constituency for the first time after his victory on Tuesday and attended a ...
2026-08-11 10:30:37

UP: Over 30,000 Women From Shgs Craft 19 Million Tricolours, Ahead Of I-Day Celebrations
(MENAFN - IANS) Lucknow, Aug 11 (IANS) As the nation-wide 'Har Ghar Tiranga' campaign seeks to remember the sacrifices of India's freedom fighters and unite every citizen with the patriotic fervour, ...
2026-08-11 10:30:34

Exam Agency Director Arrested From Mumbai In 2022 JSSC Junior Engineer Paper Leak Case
(MENAFN - IANS) Ranchi, Aug 11 (IANS) A Special Investigation Team (SIT) of the Ranchi police has arrested the director of the agency responsible for conducting the Jharkhand Staff Selection ...
2026-08-11 10:30:33

Citi bullish on MongoDB stock, expects ’significant positive estimate revisions’
Citi bullish on MongoDB stock, expects ’significant positive estimate revisions’
2026-08-11 10:30:10

Syria sentences absent Bashar al-Assad to death over killings, torture
Syria sentences absent Bashar al-Assad to death over killings, torture melissa_fernan... Tue, 11 Aug 2026 - 18:30 A Syrian court sentenced ousted leader Bashar al-Assad to death on Tuesday after a trial in absentia, convicting him of crimes including killings, torture, and arbitrary arrest during the country's nearly 14-year war. It was the first conviction against Assad, who was ousted in a rebel offensive in December 2024 that ended decades of his family's iron-fisted rule over Syria, and the brutal war that killed hundreds of thousands of Syrians. Assad fled the capital Damascus as rebel fighters approached nearly two years ago, and is currently in Moscow. In a trial of former government officials on Tuesday, a judge handed down a death sentence to Assad over the crimes of "premeditated and intentional murder of more than one person and of children, torture, arbitrary arrest and crimes against humanity". Atef Najib, a security official under Assad, was also sentenced to death. Assad, who was born in 1965, became president in 2000 after his father Hafez died. He maintained the family's rule and the dominance of their Alawite sect in the Sunni Muslim-majority country and Syria's status as an Iranian ally hostile to Israel and the U.S. Shaped in its early years by the Iraq war and crisis in Lebanon, Assad's rule was defined by civil war, which spiralled out of the 2011 Arab Spring, when Syrians demanding democracy took to the streets, to be met with deadly force. Disable Ads Off Brand Safe On A Syrian court sentenced ousted leader Bashar al-Assad to death on Tuesday after a trial in absentia, convicting him of crimes including killings, torture, and arbitrary arrest during the country's nearly 14-year war. It was the first conviction against Assad, who was ousted in a rebel offensive in December 2024 that ended decades of his family's iron-fisted rule over Syria, and the brutal war that killed hundreds of thousands of Syrians. Assad fled the capital Damascus as rebel fighters approached nearly two years ago, and is currently in Moscow. In a trial of former government officials on Tuesday, a judge handed down a death sentence to Assad over the crimes of "premeditated and intentional murder of more than one person and of children, torture, arbitrary arrest and crimes against humanity". Atef Najib, a security official under Assad, was also sentenced to death. Assad, who was born in 1965, became president in 2000 after his father Hafez died. He maintained the family's rule and the dominance of their Alawite sect in the Sunni Muslim-majority country and Syria's status as an Iranian ally hostile to Israel and the U.S. Shaped in its early years by the Iraq war and crisis in Lebanon, Assad's rule was defined by civil war, which spiralled out of the 2011 Arab Spring, when Syrians demanding democracy took to the streets, to be met with deadly force. Main Image Image Disable Ads Off Brand Safe On Post to Facebook On Post to X (Twitter) On Sub Category Global News Google analytics counter 0 Placeline DAMASCUS External authors 7
2026-08-11 10:30:10

Golf: Om Prakash Chouhan Fires 62 To Take Lead At PGTI Event In Kolkata
(MENAFN - IANS) Kolkata, Aug 11 (IANS) Om Prakash Chouhan fired an eight-under 62 to take the opening-round lead at the second edition of the INR 1 crore Coal India Open at Tollygunge Club in ...
2026-08-11 10:30:05

Watch: 4 dead, 3 rescued, 6 missing in Baguio landslide
Good day. Welcome to The Manila Times, where we bring you stories that shape our world. Today is August 10th. Our top story: Search and rescue operations continue for six persons who were buried in a landslide in Baguio City. The landslide hit three houses at Riverside, Guisad Surong following ten days of continuous rains. Three victims were rescued. Four others died in the landslide. Three of the fatalities were students, aged 17, 9, and 9. The fourth was a 56-year-old man. There are three survivors — two aged 27 and a 77-year-old pastor. They were brought to a hospital for medical observation. The southwest monsoon, or habagat, is expected to bring heavy to intense rains to several areas of Luzon. These areas are Zambales, Bataan, and Occidental Mindoro. PAGASA also said Benguet will experience intense to torrential rainfall. Metro Manila, meanwhile, will have moderate to heavy rainfall. Due to the rains, flooding hit several parts of Manila this morning. Gutter-deep flooding was reported along Taft Avenue. Bad weather also prompted at least 17 local government units in Metro Manila to suspend classes at all levels. Read more: https://tmt.news/2401660 The Senate has postponed the impeachment trial of Vice President Sara Duterte due to the projected heavy rainfall caused by the southwest monsoon. The trial resumes tomorrow. Senate President Sherwin Gatchalian also allowed all Senate officials and employees to work from home. THE HOUSE OF REPRESENTATIVES likewise shifted to a work-from-home arrangement and canceled its plenary session for today. Read more: https://tmt.news/2401682 Filipino tennis ace Alex Eala has been eliminated in the National Bank Open in Toronto, Canada. She lost to Swiss Belinda Bencic in their Round of 16 match. Bencic won in straight sets, 6–4, 6–0. She now faces Coco Gauff in the quarterfinals. Read more: https://tmt.news/2401671 For more news and information, read The Manila Times in print, subscribe to its digital edition, or log on to www.manilatimes.net. Follow us on Facebook, Instagram, X, TikTok, and LinkedIn, and be part of our communities on Viber, Telegram, WhatsApp, and Mastodon. That’s all for now on The Manila Times newscast. Stay tuned for more updates throughout the day, and remember to stay safe, stay informed, and stay connected.
2026-08-10 08:38:58

SMPC cuts 462 jobs as coal outlook dims
Semirara Mining and Power Corp. (SMPC) is cutting 462 mine-site jobs as coal production targets are slashed by over one-third and uncertainty looms over its coal operating contract expiring in 2027. Learn how the Consunji-led miner plans to support affected workers with separation benefits, retraining, redeployment within the DMCI Group, and livelihood assistance amid a shifting energy and emissions landscape.
2026-08-10 08:38:35

The Rama Legacy of Family and Public Service
Join us on Beyond the Headlines as Cebu City Councilor Mikel Rama and his father, former Cebu City Mayor Michael Rama
2026-08-10 08:38:34

Bank of America sees Treasury curve biased to steepen

2026-08-10 08:38:09

Why is Silence Therapeutics stock surging today?

2026-08-10 08:38:08

iTHINK | Judgment in the Age of AI
Artificial intelligence has made creating and accessing information faster and easier, but it has also made it harder to distinguish what is real from what is merely convincing. The post iTHINK | Judgment in the Age of AI appeared first on Newsbytes.PH .
2026-08-10 08:38:06

Serstech CFO to leave the company
Serstech today announces that CFO Simon Persson has decided to leave the company after being offered a CEO position at a non-competing startup. Simon will remain in his role throughout his notice period, until 10 November. The recruitment process for his successor will commence immediately. "I would like to thank Simon for his excellent work and for his many valuable contributions to Serstech. We wish him every success in his new role,” says Stefan Sandor, CEO of Serstech. For further information, please contact: Stefan Sandor, CEO, Serstech AB Phone: +46 739 606 067 Email: ss@serstech.com or Arve Nilsson, Chairman of the Board, Serstech AB Phone: +45 40 35 82 65 Email: arve.nilsson@serstech.com or visit: www.serstech.com Certified advisor to Serstech is Svensk Kapitalmarknadsgranskning AB (SKMG). About Serstech Serstech delivers solutions for chemical identification and has customers around the world, mainly in the safety and security industry. Typical customers are customs, police authorities, security organizations and first responders. The solutions and technology are however not limited to security applications and potentially any industry using chemicals of some kind could be addressed by Serstech’s solution. Serstech’s head office is in Sweden and all production is done in Sweden. Serstech is traded at Nasdaq First North Growth Market and more information about the company can be found at www.serstech.com
2026-08-10 08:37:13

Istanbul Care Announces Updated 2026 Hair Transplant Packages for International Patients Traveling to Turkey
ISTANBUL, Turkey , Aug. 10, 2026 (GLOBE NEWSWIRE) -- Istanbul Care today announced updated 2026 hair transplant treatment packages for international patients traveling to Istanbul, introducing clearer package-based pricing across its FUE Sapphire, Organic DHI and Gold DHI Ultra treatment options. The company said the updated package structure is designed to give prospective international patients greater clarity when comparing hair restoration treatment options, costs and services before traveling to Turkey. Under Istanbul Care's currently published 2026 pricing, Turkey hair transplant cost start at $1,990 for FUE Sapphire, $2,290 for Organic DHI, and $2,490 for Gold DHI Ultra. The company states that package prices can cover the procedure and selected international-patient services, with specific inclusions confirmed as part of the patient's treatment plan. Istanbul Care Updates Its 2026 Hair Transplant Offering The updated package structure covers three treatment options designed for different patient requirements. The FUE Sapphire package, currently listed at $1,990, uses follicular unit extraction with sapphire blades for recipient-site creation. The Organic DHI package, listed at $2,290, uses Direct Hair Implantation technology and is positioned by Istanbul Care as an option for patients for whom DHI is considered appropriate following assessment. The company's Gold DHI Ultra package, currently listed at $2,490, represents its higher-tier package and includes additional services specified by Istanbul Care as part of the package offering. Istanbul Care says the treatment approach should be determined according to the patient's individual hair-loss characteristics, donor area and treatment objectives rather than selected solely according to package price. Updated Packages Target International Medical Travelers Istanbul Care's announcement comes as the company continues to serve patients traveling to Turkey for hair restoration and other medical treatments. The company's international-patient service model includes treatment coordination and travel-related assistance. Istanbul Care currently lists hair transplantation, dental treatment, plastic surgery and obesity surgery among its services for international patients. For hair-transplant patients, the company also publishes information regarding package components, accommodation and airport-transfer arrangements as part of its international treatment offering. The company said the objective of the updated package information is to make it easier for patients to understand the available options before arranging international travel. Greater Focus on Upfront Treatment Information According to Istanbul Care, international patients often need to evaluate more than the procedure itself when planning treatment abroad. Before booking, patients can review the proposed technique, expected graft requirements, treatment plan, package inclusions and post-operative arrangements with the provider. Istanbul Care's updated 2026 information provides patients with published starting prices for its principal hair-transplant packages, while final treatment recommendations remain subject to individual assessment. Istanbul Care Continues International Patient Support Istanbul Care provides coordination services for patients traveling to Turkey for medical and aesthetic procedures. The company's service portfolio includes FUE, DHI and Sapphire FUE hair transplantation alongside other medical and aesthetic treatments. The organization supports international patients with treatment coordination and travel logistics, including accommodation and airport-transfer arrangements where included in the selected package. As part of its updated 2026 offering, Istanbul Care is encouraging prospective patients to review package details and treatment recommendations with its team before making travel arrangements. About Istanbul Care Istanbul Care is a healthcare service provider based in Istanbul, Turkey, supporting international patients seeking hair restoration and other medical and aesthetic treatments. The company's services include hair transplantation, dental treatments, plastic surgery and obesity surgery. Istanbul Care provides international patients with treatment coordination and related travel services as part of its medical-tourism offering. For more information about Istanbul Care's current hair-transplant packages and services, visit the company's website. Media Contact: Email: info@istanbul-care.com Company: Istanbul Care Clinic Website: https://istanbul-care.com/
2026-08-10 08:37:01

Festi hf.: Transactions in relation to a share repurchase programme - week 32
In week 32 2026, Festi purchased in total 265,000 own shares for total amount of 81,677,500 ISK as follows: WeekDateTimePurchased sharesShare pricePurchase price 324.8.202610:49:2440.000308,512.340.000325.8.202611:02:1559.595308,518.385.058325.8.202611:11:4415.405308,54.752.443326.8.202612:01:1475.000308,523.137.500327.8.202611:20:1975.000307,523.062.500 265.000 81.677.500 The execution of the buyback program is in accordance with the Act on Public Limited Companies No 2/1995, Article 5 of the Regulation of the European Parliament and of the Council No. 596/2014, on market abuse, the Commission Delegated Regulation No. 2016/1052 and the Act on Actions against Market Fraud No. 60/2021. Before these purchases, Festi held 4,678,864 own shares, corresponding to 1.50% of the issued share capital. Festi has now purchased a total of 1,265,000 own shares for 394,882,500 ISK and currently holds 4,943,864 own shares, corresponding to 1.58% of the issued share capital. This is an announcement of Festi’s purchase of own shares in accordance with the buyback program announced on 1 July 2026 in an announcement to Nasdaq Iceland. The program envisages the buyback of up to 3,000,000 own shares, corresponding to 0.96% of the issued share capital, provided that the total purchase price under the program shall not exceed ISK 1,000 million. For further information contact Magnús Kr. Ingason, CFO of Festi hf. (mki@festi.is).
2026-08-10 08:36:58

Marcos appoints PhilHealth chief as new DOH secretary
By Betheena Unite President Marcos has appointed acting PhilHealth President and chief executive officer (CEO) Edwin Mercado as new Secretary of the Department of Health (DOH). Mercado will replace outgoing Health chief Jose Pujalte, Jr., who was appointed by Marcos in July. The appointment of Mercado came nearly a month after Marcos named Pujalte as [...]
2026-08-10 08:35:38

Myanmar's Min Aung Hlaing seeks legitimacy in Thailand
Myanmar’s junta chief turned president Min Aung Hlaing wrapped up a two-day visit to Thailand on Friday. His first visit to the neighboring nation as civilian leader was aimed at recasting himself as the leader of a civilian government after years of diplomatic isolation, experts told DW. His reception on landing in Bangkok on Thursday had all [...]... Keep on reading: Myanmar's Min Aung Hlaing seeks legitimacy in Thailand
2026-08-09 06:40:00

Lionel Messi's father Jorge dies aged 68
Jorge Messi, the father and agent of Lionel Messi, has died aged 68, the eight-time Ballon d’Or winner’s childhood club Newell’s Old Boys announced on Saturday. Argentine media reported Jorge Messi had passed away on Friday in a hospital in his hometown of Rosario. “His constant companionship and behind-the-scenes leadership were essential in backing every step of Lionel,” Newell’s Old Boys said in a social media post. READ: Lionel Messi on Argentina World Cup loss: ‘The pain is immense’ The 39-year-old Argentine star arrived in his home country on Saturday alongside his partner, Antonela Roccuzzo, and their children, with most dressed [...]... Keep on reading: Lionel Messi's father Jorge dies aged 68
2026-08-09 06:39:20

Cleanest River
Who would take a bath or wash clothes in a river that cuts through the middle of the city? Residents of Oroquieta City in Misamis Occidental, particularly those living by the bank of the Layawan River, do, as photographed Sunday morning (9 August 2026). MindaNews photo by BOBBY TIMONERA
2026-08-09 06:38:29

Animam, Dela Rosa banner Gilas Women for pre-OQT
The Gilas Pilipinas women’s team will be leaning on its twin towers Jack Animam and Kacey Dela Rosa in its bid in the FIBA Women’s Olympic pre-Qualifying Tournament 2026 in Guadalajara, Mexico from Aug. 18 to 24. The twin towers will also have Gilas veterans Afril Bernardino and Janine Pontejos together with Filipina-American and former Duke University standout Vanessa de Jesus. Also part of the crew are Kent Pastrana, Louna Ozar, Jhaz Joson, Angel Surada, Monique Del Carmen and Alyssa Rodriguez and young gun Sophia Dignadice. The tournament will also serve as the first acid test for the Gilas women’s head coach Burke ‘BT’ Toews. Although the new Gilas coach is hoping for a good showing from his charges, he is also tempering expectations especially against some of the high-ranking teams in its group. The Nationals are drawn in Group B where they will play a single-round robin group stage against Canada, host Mexico and Senegal. "It would be great to win the Olympic Pre-Qualifying Tournament in Mexico, but that's going to be a huge hurdle for us. It would be, I think, world news if it happened,” admitted Toews. “You've got Canada in there. But there are teams in our pool that are definitely beatable. And so that's what we focus on. And the first game is against the hosts," he added. The world No. 30 opens its campaign against the Mexicans on Aug. 18 before taking on the Canadians on Aug. 20 and then closing the group stage against the Senegalese on the 21st. The Nationals are eyeing one of the top two spots in its group to advance to the semifinals.
2026-08-09 06:38:00

Asus Pad (T3201) Full Specs, Features, Price In Philippines
Here’s The Complete List of Specifications, Features, & Price of the Asus Pad (T3201) The Asus Pad (T3201) was officially announced on July 17, 2026, and released on August 06, 2026. The tablet is fueled with a Li-Po 9000 mAh battery + 45W wired charging. It was launched in a single color, Pure White. Body ... Read more The post Asus Pad (T3201) Full Specs, Features, Price In Philippines appeared first on PhilNews .
2026-08-09 06:35:19

Rep. Marcos wants national celebration of West PH Sea arbitral ruling
House Majority Leader Sandro Marcos wants a national commemoration of the arbitral ruling on the West Philippine Sea.
2026-08-09 06:33:17

Another day, another Chinese rocket? PCG warns Cagayan fisherfolk, coastal residents of debris risk from Hainan launch
Fisherfolk and coastal residents in Cagayan were advised to keep away from two designated sea areas on Monday night, Aug. 10, as a Chinese rocket is set for launch from Hainan. The Philippine Coast Guard (PCG) said it had directed concerned units to implement precautionary measures for the rescheduled launch of China's Long March 7A rocket between 7:54 p.m. and 9:16 p.m. The Coast Guard District North Eastern Luzon (CGDNELZN) said the rocket would be launched from the Wenchang Space Launch Site in Hainan, China. “Two drop zones have been identified near Cagayan: Drop Zone 1, approximately 62 nautical miles from Dalupiri Island, Calayan, and Drop Zone 2, approximately 71 nautical miles from Santa Ana,” the PCG said. The coast guard issued navigational warnings and imposed temporary restrictions in the affected waters ahead of the launch to keep vessels and other sea users away from areas identified as potential drop zones during the launch window. The PCG also warned residents against handling any suspected rocket debris that may be found in the waters or along coastal areas. “The public is reminded not to retrieve suspected rocket debris. Any sighting should be immediately reported to the nearest PCG station for appropriate measures,” the PCG said. Monday’s launch will mark the fourth time in less than three weeks that China sent a rocket into space, with its debris falling into the Philippine waters. Last week, the PCG advised fishermen and other maritime stakeholders to stay away from part of the Philippine exclusive economic zone (EEZ) off Cagayan following the launch of the Jielong-3 rocket on Aug. 5. A day after, the PCG recovered a suspected rocket debris off Calayan, Cagayan. A similar advisory was issued by the PCG after China launched the Long March 6A rocket from the Taiyuan Satellite Launch Center in Shanxi Province on July 30. The PCG also warned fishermen and mariners to stay away from waters off Northern Luzon on July 22 after China pushed through with the launch of the Yinli-1 (Y4) rocket.
2026-08-09 06:33:00

PNP: Posthumous recognition for Negros cop who died in rescue attempt
MANILA, Philippines—A police officer who died trying to save two people swept away in a river in Cadiz City, Negros Occidental, will receive posthumous recognition from the Philippine National Police (PNP). Police Master Sergeant Fernando Marfa, 40, died after being swept downstream while trying to rescue two Bantay Dagat members caught in strong currents. READ:
2026-08-09 06:32:28

Dozens of ferry trips canceled as ‘habagat’ brings rough seas
CALAPAN CITY, Oriental Mindoro, Philippines— Dozens of sea trips were canceled on Sunday, Aug. 9, as the southwest monsoon or habagat continued to bring bad weather and rough seas in several parts of the country. In its afternoon advisory, the Philippine Ports Authority (PPA) listed canceled trips involving ports in the Mimaropa and Bicol Regions,
2026-08-09 06:32:28

Who is Belinda Bencic? Alex Eala's Round of 16 foe at Canadian Open
Higher stakes will be on the line when Alex Eala returns to Centre Court of the WTA1000 Canadian Open as she takes on Belinda Bencic in the Round of 16.
2026-08-09 06:31:43

Dimples Romana walang tampo kay Bea Alonzo kahit hindi invited sa wedding
KAHIT nagtapos na ang “Gud Morning Kapatid” kahapon, Agosto 7, ay mapapanood pa rin Dimples Romana sa Kapatid network sa series na “Someone Someday” at sa bagong “Frontline sa Umaga”. Ang pumalit sa “Gud Morning Kapatid” ay ang “Frontline sa Umaga” na mapapanood na sa Lunes, Agosto 10 with Ed Lingao, Andrei Felix, Angela Lagunzad-Castro,
2026-08-08 04:30:40

Perry Mariano double-slay suspect nabbed in drug bust
By Trixee Rosel A 38-year-old man linked to the April 28 fatal shooting of businessman Perry Mariano and his driver in Quezon City was arrested during a drug buy-bust operation in Kapatagan, Lanao del Norte, on Aug. 6. Alias “Kidong,” a resident of Barangay Poblacion, Kapatagan, was nabbed at around 1:45 p.m. in Purok 10, [...]
2026-08-08 04:30:35

Lindsay Clancy trial spotlights her psychiatric care before she killed her 3 children
(Content warning: This story contains mentions of murder.) Lindsay Clancy's murder trial zeroed in Friday on her psychiatric care before she killed her three children, with testimony tracing a monthslong path to a final appointment the day before the tragedy. In that virtual visit on Jan. 23, 2023, the Massachusetts mother appeared depressed, said she felt no motivation and reported bouts of heart-racing anxiety, psychiatrist Dr. Jennifer Tufts told jurors. But she said Clancy gave no indication of hearing voices that, according her defense, commanded her the next day to take her children's lives so she could end her own. “Did she tell you that she was planning to kill the children?” prosecutor Jennifer Sprague asked. “No,” Tufts replied. “Absolutely not.” Clancy's psychiatric treatment is a key chapter in both the prosecution and defense narratives about her mental state when she strangled the children in their suburban home and then jumped out a second-story window. In questioning Tufts and a different psychiatrist who treated Clancy during a five-day hospital stay in early January 2023, prosecutors underscored that the defendant denied wanting to hurt anyone else or planning to kill herself. Clancy's lawyer, meanwhile, aimed to flesh out the defense's claim that various providers didn't properly diagnose her and put her on a series of medications that left her worse off. Clancy has pleaded not guilty to murder charges in the strangling deaths of Callan, Dawson and Cora Clancy, who ranged from 8 months to 5 years old. They were found in the basement of the family's home in coastal Duxbury, Massachusetts, and their mother was lying, badly injured, in the yard. She remains paralyzed from the waist down. Prosecutors argue that Lindsay Clancy, a 35-year-old former labor and delivery nurse, was an intentional killer who attacked her children after getting her husband out of the house by asking him to run errands. The defense doesn't dispute that she killed the children but says she was so mentally ill that she shouldn't be held criminally responsible. In the criminal trial and a medical malpractice lawsuit, Clancy's attorneys say she had bipolar disorder and postpartum psychosis — a break with reality that a small fraction of women have after childbirth. When Clancy first sought care Tufts first saw Clancy in September 2022. Consulting her notes on the witness stand Friday, she recalled that Clancy reported feeling anxious, “overwhelmed” by caring for the three children and worried about infant Callan's refusal to bottle-feed. Her maternity leave was set to end, though she would go on to extend it. Tufts diagnosed generalized anxiety disorder and an adjustment disorder with depressed mood, and she recommended therapy and an antidepressant. It became the first in a constantly-remixed cocktail of drugs that Tufts and others prescribed as Clancy reported increasing symptoms, complained of side effects and questioned whether the pills were making her worse. Clancy's malpractice suit argues that her mounting anxiety and sleeplessness after that first antidepressant were a reaction that signaled bipolar illness. Tufts said she considered such a diagnosis in December 2022 but that Clancy didn't meet the criteria. Another provider, a nurse-practitioner, did consider bipolar disorder and prescribed an antipsychotic that's often used to treat it, as well as insomnia. Clancy's condition continued declining. Clancy's stay in a psychiatric hospital By New Year's Day 2023, Clancy checked herself into McLean Hospital, a prominent psychiatric facility. Clancy said she felt numb and expressed concerns about depending on the antipsychotic to sleep, hospital psychiatrist Dr. Alia Goodheart testified Friday. She diagnosed Clancy with insomnia with a mental health condition and tapered down the drug. Clancy then reported she could sleep, was eager to go home in time for a long-planned belated birthday party for Cora, and booked herself follow-up outpatient care, the psychiatrist testified. The hospital discharged her that Jan. 5 with prescriptions for an antianxiety drug and a sleep aid. “She had never stated that she had any thoughts of harming anybody else,” Goodheart told jurors. And although Clancy said she'd had suicidal thoughts, she denied having them in the moment and indeed said she had reasons not to take her own life: “her children and her family, her mother,” Goodheart recalled. Clancy saw Tufts, her original outpatient psychiatrist, by video four more times that January. At their last appointment, Tufts adjusted her medication dosages. She saw no reason to order Clancy to be hospitalized, she said. Defense lawyer Kevin Reddington hasn't yet had his turn to question Tufts. But in questioning Goodheart, he emphasized that the hospital care team didn't do various tests — Goodheart said they weren't necessary — or learn that Clancy had called a suicide hotline that fall. Nor did the providers talk to her outpatient clinicians. “She was very sick, wasn’t she?” Reddington asked at one point. “I don’t know what you mean,” Goodheart responded. If convicted of murder, Clancy faces life in prison without parole. If found not guilty due to a lack of criminal responsibility, she would be committed to a state mental health facility.
2026-08-08 04:30:00

Six dead as Luis, Maymay, Habagat batter Luzon
Six people are dead and thousands affected as Typhoons Luis and Maymay, along with the Southwest Monsoon (Habagat), batter Luzon with floods, landslides and rockslides. Learn how Benguet, Rizal, La Union and other regions are coping with casualties, evacuations, damaged homes, and disrupted sea travel as rains persist into next week.
2026-08-08 04:29:18

Marcos orders Quiaoit River dredging, funding for diversion channels in Ilocos Norte to prevent flooding
MANILA, Philippines — President Ferdinand Marcos Jr. has ordered round-the-clock dredging operations along the Quiaoit River and the funding of two diversion channels to protect residents of Ilocos Norte from recurring floods, Public Works Secretary Vince Dizon said on Saturday. Dizon told The Manila Times that the Chief Executive issued the directives following the severe flooding that hit the municipalities of Paoay and Batac during the onslaught of Typhoon ‘Kiyapo,’ stressing the need for permanent flood mitigation measures as the rainy season continues. "The President ordered continuous dredging of the Quiaoit River and instructed us to fund the construction of two diversion channels to prevent a repeat of the massive flooding experienced by residents," according to the Department of Public Works and Highways (DPWH) chief after inspecting the area late last week with the president's son, Ilocos Norte First District Rep. Sandro Marcos. The Quiaoit River, which runs through Paoay and Batac, has repeatedly overflowed during periods of heavy rainfall, inundating residential communities and agricultural areas, the DPWH said. Dizon said sustained dredging operations would increase the river's carrying capacity by removing accumulated silt and other obstructions, allowing floodwaters to flow more efficiently. He added that the two diversion channels would serve as additional waterways that could redirect excess water away from populated communities during intense rains and typhoons. The directives are part of the administration's continuing efforts to strengthen flood-control infrastructure nationwide following the widespread devastation caused by recent weather disturbances, the public works department said. The DPWH chief said they would implement the president's instructions immediately, with continuous dredging to begin while preparations for the construction of the diversion channels were being undertaken.
2026-08-08 04:29:02

Jeric Gonzales celebrates his birthday with gratitude
Some friends from the industry also greeted Jeric Gonzales on his birthday.
2026-08-08 04:21:47

Ukraine promised to end attacks on US-linked oil terminal Bloomberg
Kiev reportedly vowed to refrain from strikes on CPC infrastructure whose shareholders include Chevron and ExxonMobil Ukraine has promised not to strike some non-Russian oil tankers or the internationally owned Black Sea pipeline terminal used to transport Kazakh crude to Europe and Asia, Bloomberg reported on Friday, citing a US official familiar with the matter. Both the US and Kazakhstan
2026-08-08 04:21:28

Ukraine promises to end attacks on US-linked oil terminal Bloomberg
Kiev reportedly vowed to refrain from strikes on CPC infrastructure whose shareholders include Chevron and ExxonMobil Ukraine has promised not to strike some non-Russian oil tankers or the internationally owned Black Sea pipeline terminal used to transport Kazakh crude to Europe and Asia, Bloomberg reported on Friday, citing a US official familiar with the matter. Both the US and Kazakhstan
2026-08-08 04:21:28

Celebrate the Mid-Autumn Festival with an Elegant Feast and Signature Mooncakes at The Manila Hotel
Out of Town Blog Celebrate the Mid-Autumn Festival with an Elegant Feast and Signature Mooncakes at The Manila Hotel As the Mid-Autumn Festival draws near, it’s once again time to gather around the table with family, friends, and colleagues to celebrate one of Asia’s most treasured traditions. This year, The Manila Hotel invites guests to embrace the spirit of reunion, gratitude, and prosperity with a specially curated dining experience and a collection of handcrafted [...] Celebrate the Mid-Autumn Festival with an Elegant Feast and Signature Mooncakes at The Manila Hotel Melo Villareal Out of Town Blog
2026-08-08 04:21:25

Alex Eala's 7-match winning streak: A look at her run from DC Open to Canadian Open
Alex Eala"s winning streak reaches seven after her Canadian Open win over Caty McNally. Here"s a look at her run from the DC Open to Toronto.
2026-08-08 04:20:28

EMERGENCE | The Polish on the Illusion: Decoding Marcos Jr.’s SONA Through a Progressive Lens
DAVAO CITY (MindaNews / 7 August 2026) – Every State of the Nation Address (SONA) is part legislative report, part carefully choreographed theater. In his latest address, President Ferdinand Marcos Jr. presented a sleek portrait of national progress—highlighting anti-corruption raids, high-tech foreign investment corridors, climate infrastructure, and target inflation control. To assess the state of [...]
2026-08-07 02:47:14

Carney says US trade talks are ‘nasty’ after Trump criticizes Canada’s leadership
TORONTO (AP) — Canadian Prime Minister Mark Carney said Thursday that trade negotiations with the United States had turned “nasty” after President Donald Trump derided America’s neighbor and its leadership while threatening to expand tariffs. Carney said Canada remained engaged in the negotiations despite Trump’s comments, describing the talks as a fight to protect Canadian workers and businesses. “This is a tough negotiation,” Carney said in French. “You can say ‘nasty.’ But this is a question of Canadian jobs. It’s a question of the future of Canadian businesses.” Trump criticized Canada during a speech Wednesday in Las Vegas. “Canada’s nasty. They are. They’re nasty,” Trump said. “I love the people, but they’re nasty. Nasty leadership.” Carney said “we are in the middle of a tariff war with the Americans” but laughed when asked about Trump’s description. He said Canadian negotiators were in Washington this week and that he expected further conversations with Trump after speaking with him last week. The United States already has tariffs on Canadian steel, aluminum and automobiles. Trump has threatened to impose 50% tariffs on more Canadian goods beginning Aug. 19. Tariffs are taxes on imports, which companies can then pass along to consumers in the form of higher prices. The president maintains that the costs created by tariffs will cause manufacturing to relocate to the U.S., though there is little evidence of that in the economic data. Trump’s tariff threats and repeated suggestions that Canada should become the 51st U.S. state have angered many Canadians, prompting many Canadians to cancel trips to the United States. U.S. Trade Representative Jamieson Greer has argued that Canada and China are the only two countries to retaliate against Trump’s tariffs, citing restrictions on U.S. alcohol sales in some Canadian provinces among his concerns. Canadian officials say their countermeasures were a response to existing U.S. tariffs. The latest comments followed months of escalating tensions. At the World Economic Forum in Davos, Switzerland, in January, Carney criticized major powers for using economic coercion against smaller countries, prompting Trump to respond: “Canada lives because of the United States. Remember that, Mark, the next time you make your statements.” Canada is one of the United States’ largest trading partners, and the move threatens to push prices higher at a time when Americans are already frustrated with the high cost of living ahead of the Nov. 3 midterm elections. Carney said existing U.S. tariffs on aluminum have contributed to a 58% increase in aluminum prices in the United States. “That’s not a good situation for American companies,” Carney said.
2026-08-07 02:46:00

Laba Day Friday - Libreng laba para sa mga Kapuso! | Unang Hirit
Aired (August 7, 2026): Dahil sa tuloy-tuloy na pag-ulan, maraming labada ang hindi agad natutuyo. Kaya naman sina Jusa at Baus ang sumagot sa libreng paglalaba ng ating mga Kapuso. Panoorin ang video. Your Trusted Online Source, The News Authority of the Filipino.
2026-08-07 02:45:41

Hindi uunlad ang Pilipinas sa paninira
Iginiit ni Dr. Jose Antonio Goitia na hindi isang failed state ang Pilipinas at ipinagtanggol ang AFP at PNP laban sa mga mapanlahat na akusasyon. The post Hindi uunlad ang Pilipinas sa paninira first appeared on Tonite - Abante .
2026-08-07 02:45:30

The Property Geek: The best time to buy real estate is when everyone else hesitates
Every real estate cycle has one thing in common: people always find a reason to wait. Today, it's inflation. Tomorrow, it could be elections. Next year, it might be interest rates, global conflicts, or economic uncertainty. The headlines change, but the hesitation remains the same. Ironically, this is often when the smartest real estate investors make their move. We're currently in what many would consider a buyer's market. Developers are offering longer and more flexible down payment terms, attractive discounts, and payment schemes that were rarely available during periods of high demand. For buyers with a long-term perspective, these conditions create opportunities that may not exist once the market gains momentum again. History has shown that real estate moves in cycles. Markets slow down, stabilize, recover, and eventually grow. While no one can predict exactly when the next upswing will happen, one thing has remained remarkably consistent: quality real estate appreciates over time. The biggest mistake many aspiring investors make is believing they should only buy when the economy feels perfect. In reality, by the time everyone becomes confident again, prices have often already increased, incentives have disappeared, and competition has returned. Legendary investor Warren Buffett once said, "Be fearful when others are greedy, and greedy when others are fearful." While his advice was directed toward the stock market, the same principle applies to real estate. Opportunity often hides behind uncertainty. This doesn't mean buying recklessly. It means investing wisely. Choose projects from reputable developers, prioritize locations with strong long-term growth drivers, and ensure that your purchase aligns with your financial capacity. Real estate should never be an emotional decision; it should be a strategic one. One advantage today's buyers enjoy is time. Extended payment terms allow many families and investors to secure tomorrow's property values while spreading out today's financial commitment. That's a luxury that often disappears when demand returns. Real estate has survived financial crises, political transitions, pandemics, and global conflicts. Yet cities continue to expand, infrastructure continues to improve, and land remains one of the few assets that cannot be created. Markets will eventually recover, as they always do. The question is not whether opportunities will disappear. The question is whether you'll still be watching from the sidelines when they do. Sometimes, the best investment decisions are made not when the market feels safest, but when you have the courage to see what others don't.
2026-08-07 02:45:00

Trip.com Group Releases 2025 Sustainability Report, Announces New Global Paid Paternity Leave Policy
Trip.com Group to introduce global minimum of 20 days paid paternity leave for employees starting August 2026 First online travel service provider in Asia Pacific with validated near-term and net-zero emissions targets by SBTi Group launches USD 100 Million Tourism Innovation Fund, recognises industry innovation with annual awards at 2025 Global Partner Conference SINGAPORE , Aug. 7, 2026 /PRNewswire/ -- Trip.com Group announces new global 20-day paid paternity leave policy for employees, reinforcing its commitment to supporting families across its global workforce. The company further releases its 2025 Sustainability Report, highlighting progress in advancing climate action, empowering communities and driving innovation across the global tourism industry. Among the report's key milestones, Trip.com Group became the first online travel company in the Asia Pacific region to have both its near-term and net-zero greenhouse gas emissions reduction targets validated by the Science Based Targets initiative (SBTi). Together, these initiatives reflect the Group's "Friendly Four" framework ( family-friendly, community-friendly, environmentally-friendly, and stakeholder-friendly ), which brings together its commitment to supporting families, communities, the environment, and industry partners while creating long-term value for travellers around the world. "Travel connects people, cultures and communities, and we believe the future of travel must also create positive outcomes for the planet and society," said Jane Sun, CEO of Trip.com Group. "Through our sustainability strategy, we are investing in our people, accelerating climate action and working with partners worldwide to build a more resilient tourism ecosystem." Supporting Families Trip.com Group continued its commitment to a family-friendly workplace through its Childcare Subsidy, which has supported over 2,038 families since its launch. In 2025, 1,114 employees benefited from this initiative, supporting over 1,132 children, with annual expenses totalling approximately USD 1.6 million. During the reporting period, the Group also maintained a 100% return-to-work rate for female employees following maternity leave. Building on this, Trip.com Group is introducing a global paternity leave policy that supplements local statutory entitlements and provides eligible employees with minimum of 20 days of paid paternity leave. The first phase will take effect on 1 August, covering selected markets across Asia, with additional regions joining later this year. By expanding support for working parents, the Group continues to foster a more inclusive workplace and promote a healthier balance between work and family life. Alongside these initiatives, Trip.com Group continued advancing workplace diversity and inclusion. Women held 33.1% of senior management positions and 52.3% of management roles within key revenue-generating functions. The Group further promoted women in STEM-related positions, with women accounting for 33.0% of all related positions. Empowering Communities Trip.com Group expanded initiatives that make tourism more inclusive while delivering meaningful benefits to local communities. The Group remains committed to empowering users via solutions that enhance the planning and booking experience. The 'Trip for Everyone' project focused on upgrading and unifying accessibility standards, covering colour contrast, scalable typography, screen reader compatibility, and keyboard navigation. The work was recognised with an iF Design Award for helping travellers with diverse physical and situational needs explore the world with more autonomy. Trip.com Group continued expanding its Country Retreat programme, supporting approximately 11,000 indirect employment opportunities during the reporting year. The initiative has supported local economies by generating around 51,000 employment opportunities over the last five years, and has hired at least 80% of local staff across its 12 properties. To help travellers access support in times of need, the Group's Global SOS Platform was upgraded to support 24 languages and 20 travel emergency scenarios. By the end of 2025, the platform had handled more than 23,000 assistance requests across over 100 destinations. Protecting the Future of Travel Climate action remained a key priority as Trip.com Group continued to reduce its environmental footprint while making lower-carbon travel choices more accessible. During the reporting period, the Group's greenhouse gas emission reduction targets were officially validated by the Science Based Targets initiative (SBTi), making Trip.com Group the first online travel company in the Asia Pacific region to have both its near-term and net-zero emissions targets validated by the SBTi. The Group also continued expanding its portfolio of more sustainable travel products across accommodation, flights, car rentals and rail. In 2025, 2.74 million users embraced lower-carbon business travel, generating 23.44 million lower-carbon travel bookings throughout the year. Growing Tourism Together Trip.com Group continued investing in the long-term growth of the tourism ecosystem through innovation, destination development, and stronger partnerships. At its 2025 Global Partner Conference, the Group launched its USD 100 million Tourism Innovation Fund to support innovative tourism projects and cross-sector collaborations that encourage new destination growth models and differentiated visitor experiences. Supporting destinations also means helping local businesses connect with travellers. By the end of 2025, Trip.com Group offered more than 350,000 in-destination experiences worldwide, including dining and shopping experiences, day tours, attraction and performance tickets, and customised guided tours, creating new opportunities for tourism suppliers while enriching travellers' journeys. The full report provides further detail on Trip.com Group's progress, key priorities, and its continued commitment to building a more inclusive, sustainable and resilient future for travel. Read the full 2025 Sustainability Report here About Trip.com Group Trip.com Group is a global travel service provider comprising of Trip.com , Ctrip, Skyscanner, and Qunar. Across its platforms, Trip.com Group helps travellers around the world make informed and cost-effective bookings for travel products and services and enables partners to connect their offerings with users through the aggregation of travel-related content and resources, and an advanced transaction platform consisting of apps, websites and 24/7 customer service centres. Founded in 1999 and listed on NASDAQ in 2003 and HKEX in 2021, Trip.com Group is on the mission "to pursue the perfect trip for a better world". Find out more about Trip.com Group here: group.trip.com . Follow us on: X , Facebook , LinkedIn , and YouTube .
2026-08-07 02:45:00

Alex Eala, Venus Williams bow out of Canadian Open doubles
MANILA, Philippines–Alex Eala and Venus Williams ended their doubles campaign after losing to Liudmila Samsonova and Miyu Kato, 6-4, 6-3, in the Canadian Open Round of 32 in Toronto on Friday. Eala and Williams, the wild-card pair playing together for only the second time, put up a fight and tied the opening set at 4-4 with a break before Samsonova and Kato found their groove, stringing together six straight games to take control of the match. READ: Alex Eala: Filipino dreamer to WTA winner The Filipino-American tandem fell behind 4-0 in the second before winning back-to-back games, including their first break [...]... Keep on reading: Alex Eala, Venus Williams bow out of Canadian Open doubles
2026-08-07 02:44:36

Campus violence betrays the July spirit: The Daily Star
The Daily Star's editorial team urges BNP and Jamaat to rein in their student fronts, ensuring that ordinary students can go back to their campuses free of fear and intimidation.
2026-08-07 02:44:05

Bohol advances plastic pollution monitoring through PlastiZen partnership with UP MSI and BISU
ON July 31, the University of the Philippines Marine Science Institute (UP MSI), through its PlastiZen Project, held a Ceremonial Signing of the Memorandum of Agreement (MOA) with the Provincial Government of Bohol and Bohol Island State University (BISU) on July 31, 2026, at the Reyna and Havens and Gardens, Calceta St., Tagbilaran City. The MOA is between the University of the Philippines Diliman (UPD), Bohol Island State University (BISU), and the Provincial Government of Bohol (PGB). Governor Erico Aristotle "Aris" Aumentado of Bohol, Dr. Deo Florence Onda, project leader of the PlastiZen Project; Edgardo Carlo Vistan II, chancellor of the University of the Philippines Diliman; and Dr. Anthony Penaso, president of Bohol Island State University, were present during the signing. Earlier in July, their citizen science application, PlastiZen Basura Patroller, was launched on Google Play, co-implemented by the Department of Mathematics and Computer Science, University of the Philippines Baguio. Funded by the Department of Science and Technology–Philippine Council for Industry, Energy and Emerging Technology Research and Development (DOST-PCIEERD), PlastiZen Basura Patroller is an app through which plastic pollution can be reported via anonymous photo submissions, allowing for the geotagging of plastic waste. The PGB, through the Bohol Provincial Environment Management Office (BPEMO), recognizes the urgent need to strengthen environmental monitoring systems and institutionalize data-driven strategies to mitigate plastic pollution while enhancing sustainable coastal and marine resource management in the province. The partnership reflects Bohol's commitment to integrating scientific research, digital innovation, and citizen participation into environmental governance, enabling more responsive and evidence-based decision-making for the province's ecosystems. Under the agreement, BPEMO will adopt the institutional use of the PlastiZen application as an environmental monitoring tool across the Province of Bohol. Through the institutional adoption of PlastiZen, Bohol aims to strengthen science-based environmental management by generating community-driven data to inform local policies and conservation initiatives. The province is officially recognized as a UNESCO Global Geopark for its globally significant geological heritage, underscoring the importance of integrated conservation, education, and sustainable development, including the protection and restoration of terrestrial, coastal, and marine ecosystems. The BPEMO will coordinate with provincial and local stakeholders to support its implementation, collaborate with state universities and colleges and national government agencies in developing communication materials for the application's promotion and use, and adopt policy recommendations and briefs derived from data collected through the PlastiZen application. Through this MOA, UPD will lead the technology transfer of the project’s citizen science PlastiZen application by designing and implementing capacity-building programs and adoption frameworks. UPD will also provide technical expertise and guidance on the application and monitoring framework, support data storage and retrieval for information collected through the PlastiZen and PlastiCount applications, and prepare consolidated technical and monitoring reports. By mapping the location and concentration of plastic pollution, geotagging provides local governments, researchers, and environmental organizations with real-time data that can guide targeted interventions, optimize resource allocation, and support evidence-based waste management policies. PlastiZen also enables long-term monitoring of pollution trends and informing strategies to prevent further waste leakage into waterways and marine ecosystems. PlastiZen Basura Patroller All data collected through the app are integrated into a central public database called the PlastiCount Pilipinas portal, creating an end-to-end data pipeline that transforms citizen-generated reports into an artificial intelligence (AI)-assisted analytical repository for monitoring and analyzing plastic pollution trends. The PlastiCount Pilipinas portal was first launched in 2022, and is the first open-source marine plastic pollution (MPP) tracker in the Philippines and Southeast Asia, covering both microplastics and macroplastics. PlastiZen also supports the Philippines’ National Plan of Action for the Prevention, Reduction, and Management of Marine Litter (NPoA-ML), adopted by the Department of Environment and Natural Resources (DENR), which has the overarching goal of achieving Zero Waste to Philippine Waters by 2040. A key component of the NPoA-ML is the establishment of science- and evidence-based baseline information on marine litter. By empowering citizens and encouraging greater awareness of the sources and continuing challenges of plastic pollution, as well as what it takes to solve them, PlastiZen represents one step toward more efficient and data-driven local waste management workflows. The ceremonial signing of the MOA builds upon the previous capacity-building efforts by formalizing long-term collaboration among UPD, BISU, and the Provincial Government of Bohol in advancing environmental monitoring and management in the province. How to use the app: 1. Open the app 2. Snap a photo of the litter 3. Submit anonymously For further information on the project’s updates, follow the Microbial Oceanography Laboratory on Facebook, or email microocelab@msi.upd.edu.ph. If you have questions or concerns about the application, you may contact the PlastiZen team directly through plastizen@msi.upd.edu.ph.
2026-08-07 02:43:00

What's next after swiping right? Green and red flags of online dating
Keeping an eye out for green flags will help the search for a potential significant other feel easier and safer.
2026-08-07 02:42:00

P100,000 halaga ng ilegal na droga, nasabat sa buy-bust operation sa Brgy. Lower Bicutan; 2, arestado
Arestado ang dalawang lalaki sa Taguig matapos mahulihan ng P100,000 halaga ng ilegal na droga. Get the latest breaking news and stories in the Philippines and around the world from GMA News Online.
2026-08-06 00:46:21

Kita ng magtataho at ng bakery, malakas daw kahit maulan
Kumustahin natin ang kita ng mga nagnenegosyo at naghahanapbuhay ngayong maulan ang panahon. Get the latest breaking news and stories in the Philippines and around the world from GMA News Online.
2026-08-06 00:46:21

House resolutions seek to honor SB19 for expanding P-pop's global reach
Two resolutions have been filed in the House of Representatives seeking to recognize SB19 for a string of international milestones that lawmakers say have elevated Filipino music and strengthened the country's tourism profile. House Resolution No. 1280, authored by Reps. Javier Miguel "Javi" Benitez, Nelson Legacion, Sarah Jane Elago and Kathryn Joyce Gorriceta, cites the group's appointment as Department of Tourism ambassadors, its performance at Lollapalooza Chicago, and member Josh Cullen's ceremonial first pitch at a Chicago White Sox game. SB19 became the first homegrown Filipino act to perform at Lollapalooza, while Josh was the first P-pop artist to throw a ceremonial first pitch before a regular-season Major League Baseball game. The resolution said SB19's international following has helped drive music tourism, attracting overseas Filipinos and foreign fans to the country for concerts. "SB19's immense international reach has directly catalyzed a surge in music tourism, inspiring returning overseas Filipino workers, many of whom have not visited the Philippines in years, as well as international fans to travel to the country to witness their concerts live on home soil, thereby generating significant economic activity, increasing hotel occupancy, and boosting national tourism," it said. It also credited the group with encouraging overseas fans to embrace Filipino culture and language. "Through their uncompromising commitment to write and perform Filipino music, SB19 has inspired thousands of foreign fans across Asia, North America, Europe, and beyond to learn the Filipino language and deeply appreciate Philippine traditions, heritage, and values," the resolution said. Benitez said SB19's success had created opportunities for future Filipino artists. "SB19 made room for the next Filipino act that follows," he said. "The work now is making sure the industries behind them, from music to tourism, are ready for the attention." A separate measure, House Resolution No. 1266, filed by Calamba Rep. Charisse Anne Hernandez, also seeks to honor the group, saying its "outstanding accomplishments exemplify excellence, resilience, innovation, and patriotism." Both resolutions are pending before the House Committee on Creative Industries.
2026-08-06 00:46:00

Singapore travellers say first holiday together more exciting than first kiss: Survey
Taking their first holiday together (47 per cent) ranked top on a list of relationship milestones, ahead of their first kiss (27 per cent) and holding hands for the first time (21 per cent), based on a survey by travel metasearch platform Skyscanner.
2026-08-06 00:45:34

Central Visayas inflation eases to 8.7% in July, but still highest in PH
CEBU CITY, Philippines — Inflation, or the general increase in the prices of basic goods and commodities, in Central Visayas slowed down in July, but the region continued to post the highest headline rate among 18 regions in the country. Headline inflation in Central Visayas last month eased to 8.7 percent, a slight improvement compared [...]... Keep on reading: Central Visayas inflation eases to 8.7% in July, but still highest in PH
2026-08-06 00:45:00

Closing the gaps in the fight against hepatitis
Earlier testing and easier access to care could help prevent liver cancer and premature deaths.
2026-08-06 00:44:18

Earnings call transcript: Kinatico posts stronger FY 2026 profit, shares fall

2026-08-06 00:44:08

Palworld Online mobile game announced by Garena, Pocketpair
Garena and Pocketpair have officially announced Palworld Online, a new mobile multiplayer survival adventure game based on the monster-collecting survival title Palworld.
2026-08-06 00:41:07

Elena Rybakina, Jessica Pegula, Coco Gauff advance at Canadian Open
TORONTO–Second seed Elena Rybakina, third seed Jessica Pegula and fourth-seeded Coco Gauff advanced to the third round of the WTA 1000 Canadian Open in Toronto on Wednesday. Australian Open champion Rybakina of Kazakhstan began her hardcourt run ahead of the US Open by outlasting Australian Daria Kasatkina 6-3, 5-7, 6-4 after two hours and 33 minutes. READ: Elena Rybakina crashes out in third round at Wimbledon World number two Rybakina began the match by hitting six consecutive winners and finished with 58 winners, 15 of them acers, and 58 unforced errors, 16 of them double faults. Rybakina hit back-to-back double faults [...]... Keep on reading: Elena Rybakina, Jessica Pegula, Coco Gauff advance at Canadian Open
2026-08-06 00:41:01

Intense rainfall outlook due to TS #MaymayPH (valid until 11 AM, August 6)
Intense rainfall outlook due to TS #MaymayPH (valid until 11 AM, August 6) . Keep up with the latest headlines on science and technology breakthroughs in the Philippines and around the world from GMA News Online.
2026-08-06 00:41:00